10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2023

or

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                to                

Commission File Number 001-40125

LOCAL BOUNTI CORPORATION

(Exact name of registrant as specified in its charter)

Delaware				98-1584830
(State or Other Jurisdiction of Incorporation or Organization)				(I.R.S Employer Identification No.)
	400 W. Main St.	Hamilton,	MT	59840
(Address of Principal Executive Offices, Including Zip Code)

(800) 640-4016

        (Registrant's Telephone Number, Including Area Code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value of $0.0001 per share	LOCL	New York Stock Exchange
Warrants, thirteen exercisable for one share of Common Stock for $149.50 per share	LOCL WS	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒    No  ☐  

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T(§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ☒    No  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Smaller reporting company	☒
		Emerging growth company	☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2of the Act).    Yes  ☐    No  ☒

The number of outstanding shares of Local Bounti Corporation's common stock was 8,271,738 at November 6, 2023.

1

TABLE OF CONTENTS

	Page
Part I – FINANCIAL INFORMATION	5
Item 1. Financial Statements
Unaudited Condensed Consolidated Balance Sheets at September 30, 2023 and December 31, 2022	5
Unaudited Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2023 and 2022	6
Unaudited Condensed Consolidated Statements of Stockholders' Equity for the three and nine months ended September 30, 2023 and 2022	7
Unaudited Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2023 and 2022	8
Notes to Unaudited Condensed Consolidated Financial Statements	10
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations	19
Item 3. Quantitative and Qualitative Disclosures About Market Risk	26
Item 4. Controls and Procedures	26
Part II – OTHER INFORMATION	28
Item 1. Legal Proceedings	28
Item 1A. Risk Factors	28
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	28
Item 6. Exhibits	29
SIGNATURES	30

2

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q and the information incorporated herein by reference contain certain statements that constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. In some cases, you can identify these forward-looking statements by the use of terms such as "expect," "anticipate," "believe," "continue," "estimate," "intend," "may," "plan," "project," "seek," "should," "target," "will," or similar expressions, and variations or negatives of these words, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking statements include, without limitation, statements regarding our ability to raise capital in the future, future financial performance, business strategies including future acquisitions, expansion plans including construction of future facilities, future results of operations, estimated revenues, losses, projected costs, prospects, plans and objectives of management. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. These forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to differ materially from results expressed or implied in this Quarterly Report on Form 10-Q. The following factors, among others, could cause actual results to differ materially from those described in these forward-looking statements:

•Local Bounti's ability to generate significant revenue;

•the risk that Local Bounti may never achieve or sustain profitability;

•the risk that Local Bounti could fail to effectively manage its future growth;

•the risk that Local Bounti will fail to obtain additional necessary capital when needed on acceptable terms or at all;

•Local Bounti's ability to complete the build out of its current or additional facilities in the future;

•Local Bounti's reliance on third parties for construction, the risk of delays relating to material delivery and supply chains, and fluctuating material prices;

•Local Bounti's ability to scale its operations and decrease its cost of goods sold over time;

•the potential for damage to or problems with Local Bounti's facilities;

•the impact that current or future acquisitions, investments or expansions of scope of existing relationships have on Local Bounti's business, financial condition, and results of operations;

•unknown liabilities that may be assumed in acquisitions;

•restrictions contained in Local Bounti's debt facility agreements with Cargill Financial Services International, Inc. ("Cargill Financial");

•Local Bounti's ability to attract and retain qualified employees;

•Local Bounti's ability to develop and maintain its brand or brands;

•Local Bounti's ability to achieve its sustainability goals;

•Local Bounti's ability to maintain its company culture or focus on its vision as it grows;

•Local Bounti's ability to execute on its growth strategy;

•the risk of diseases and pests destroying crops;

•Local Bounti's ability to compete successfully in the highly competitive natural food market;

•Local Bounti's ability to defend itself against intellectual property infringement claims;

•Local Bounti's ability to effectively integrate the acquired operations of any CEA or similar operations which it acquires into its existing operations;

•changes in consumer preferences, perception, and spending habits in the food industry;

•the risk that seasonality may adversely impact Local Bounti's results of operations;

•Local Bounti's ability to repay, refinance, restructure, or extend its indebtedness as it comes due;

•Local Bounti's ability to comply with the continued listing requirements of the New York Stock Exchange ("NYSE");

•Local Bounti's ability to implement any share repurchase program; and

•the other factors discussed in Item 1A, "Risk Factors" of the Company's most recent Annual Report on Form 10-K and any updates to those factors set forth in Local Bounti's subsequent Quarterly Reports on Form 10-Q or Current Reports on Form 8-K.

The forward-looking statements contained herein are based on our current expectations and beliefs concerning future developments and their potential effects on our business. There can be no assurance that future developments affecting our business will be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, the "Risk Factors" identified in Part I, Item 1A of the Company's most recent Annual Report on Form 10-K. Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time and it is not possible for us to predict all such risk factors, nor can we assess the effect of all such risk factors on our business or the extent to which any factor or combination of factors may cause actual results to differ materially from those contained in any forward-looking

3

statements. Should one or more of these risks or uncertainties materialize, or should any of the assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements.

In light of these risks and uncertainties, there is no assurance that the events or results suggested by the forward-looking statements will in fact occur, and you should not place undue reliance on these forward-looking statements. The forward-looking statements made by us in this Quarterly Report on Form 10-Q speak only as of the date made. Local Bounti undertakes no obligation, other than as required by applicable law, to update or revise its forward-looking statements, whether as a result of new information, subsequent events, anticipated or unanticipated circumstances or otherwise.

WEBSITE AND SOCIAL MEDIA DISCLOSURE

Investors and others should note that we routinely announce material information to investors and the marketplace using filings with the SEC, press releases, public conference calls, presentations, webcasts and our website. We also intend to use certain social media channels as a means of disclosing information about Local Bounti and our products to our customers, investors and the public (e.g., @Local Bounti and #LocalBounti on X). The information posted on social media channels is not incorporated by reference in this Quarterly Report on Form 10-Q or in any other report or document we file with the SEC. While not all of the information that we post to our website or social media accounts is of a material nature, some information could be deemed to be material. Accordingly, we encourage investors, the media, and others to sign up for and regularly follow our social media accounts. Users may automatically receive email alerts and other information about Local Bounti by signing up for email alerts under the "Investors" section of our website at https://investors.localbounti.com.

ADDITIONAL INFORMATION

Unless the context indicates otherwise, references in this Quarterly Report on Form 10-Q to the "Company," "Local Bounti," "we," "us," "our" and similar terms refer to Local Bounti Corporation and its consolidated subsidiaries.

On June 15, 2023, we effected a 1-for-13 reverse stock split of our common stock. All common share and per share amounts throughout this Quarterly Report on Form 10-Q have been restated to reflect the 1-for-13 reverse stock split. See Note 2, Summary of Significant Accounting Policies, for additional detail.

4

 PART I - FINANCIAL INFORMATION

Item 1. Financial Statements

LOCAL BOUNTI CORPORATION

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except share and per share data)

	September 30,		December 31,
	2023		2022
Assets
Current assets
Cash and cash equivalents	$	11,814	$	13,666
Restricted cash	6,524		11,272
Accounts receivable, net	2,666		2,691
Inventory, net	4,493		3,594
Prepaid expenses and other current assets	2,295		2,881
Total current assets	27,792		34,104
Property and equipment, net	268,099		157,844
Operating lease right-of-use assets	190		137
Goodwill	38,481		38,481
Intangible assets, net	42,246		47,273
Other assets	674		901
Total assets	$	377,482	$	278,740
Liabilities and stockholders' equity
Current liabilities
Accounts payable	$	9,041	$	13,757
Accrued liabilities	15,621		9,426
Operating lease liabilities	91		84
Total current liabilities	24,753		23,267
Long-term debt, net of debt issuance costs	216,958		119,814
Financing obligation	49,057		14,139
Operating lease liabilities, noncurrent	133		187
Warrant liability	8,780		—
Total liabilities	299,681		157,407
Commitments and contingencies (Note 11)
Stockholders' equity
Common stock, $0.0001 par value, 400,000,000 shares authorized, 8,268,639 and 7,976,980 issued and outstanding as of September 30, 2023 and December 31, 2022, respectively(1)	1		1
Additional paid-in capital	315,574		300,645
Accumulated deficit	(237,774)		(179,313)
Total stockholders' equity	77,801		121,333
Total liabilities and stockholders' equity	$	377,482	$	278,740

(1) Prior comparative period share amounts issued and outstanding have been retroactively adjusted to reflect the Reverse Stock Split (as defined below). See Note 2, Summary of Significant Accounting Policies, for additional detail.

See accompanying Notes to Unaudited Condensed Consolidated Financial Statements

5

LOCAL BOUNTI CORPORATION

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except share and per share data)

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
Sales	$	6,810	$	6,285	$	20,691	$	12,836
Cost of goods sold(2)(3)(4)	6,405		5,015		19,155		11,535
Gross profit	405		1,270		1,536		1,301
Operating expenses:
Research and development(3)(4)	5,001		3,019		12,103		8,933
Selling, general and administrative(3)(4)	14,406		20,239		47,091		64,741
Total operating expenses	19,407		23,258		59,194		73,674
Loss from operations	(19,002)		(21,988)		(57,658)		(72,373)
Other income (expense):
Change in fair value of warrant liability	1,766		—		16,917		—
Interest expense, net	(7,105)		(5,154)		(17,876)		(12,262)
Other income	83		38		156		96
Net loss	$	(24,258)	$	(27,104)	$	(58,461)	$	(84,539)
Net loss applicable to common stockholders per basic common share:
Basic and diluted(1)	$	(3.02)	$	(3.95)	$	(7.41)	$	(12.73)
Weighted average common shares outstanding:
Basic and diluted(1)	8,019,561		6,865,001		7,893,665		6,639,879

(1) Prior comparative period share and per share amounts have been retroactively adjusted to reflect the Reverse Stock Split (as defined below). See Note 2, Summary of Significant Accounting Policies, for additional detail.

(2) Amounts include the impact for non-cash increase in cost of goods sold attributable to the fair value basis adjustment to inventory in connection with the Pete's Acquisition (as defined below) as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
Cost of goods sold	$	—	$	—	$	—	$	1,042
Total business combination fair value basis adjustment to inventory	$	—	$	—	$	—	$	1,042

(3) Amounts include stock-based compensation as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
Cost of goods sold	$	24	$	29	$	100	$	81
Research and development	343		419		1,676		1,389
Selling, general and administrative	2,898		10,459		11,882		32,146
Total stock-based compensation expense, net of amounts capitalized	$	3,265	$	10,907	$	13,658	$	33,616

(4) Amounts include depreciation and amortization as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
Cost of goods sold	$	832	$	921	$	2,662	$	1,874
Research and development	722		229		1,754		760
Selling, general and administrative	1,851		1,757		5,763		4,195
Total depreciation and amortization	$	3,405	$	2,907	$	10,179	$	6,829

See accompanying Notes to Unaudited Condensed Consolidated Financial Statements

6

LOCAL BOUNTI CORPORATION

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2023 and 2022

(in thousands, except share data)

	Voting Common Stock(1)			Additional Paid-in Capital		Accumulated Deficit		Total Stockholders' Equity
	Shares	Amount
Balance, December 31, 2022	7,976,980	$	1	$	300,645	$	(179,313)	$	121,333
Vesting of restricted stock units, net	41,502	—		—		—		—
Stock-based compensation	—	—		6,361		—		6,361
Net loss	—	—		—		(23,527)		(23,527)
Balance, March 31, 2023	8,018,482	1		307,006		(202,840)		104,167
Vesting of restricted stock units, net	171,051	—		—		—		—
Cash paid for fractional shares from the Reverse Stock Split	(552)	—		(3)		—		(3)
Stock-based compensation	—	—		4,792		—		4,792
Net loss	—	—		—		(10,676)		(10,676)
Balance, June 30, 2023	8,188,981	1		311,795		(213,516)		98,280
Vesting of restricted stock units, net	79,658	—		—		—		—
Stock-based compensation	—	—		3,779		—		3,779
Net loss	—	—		—		(24,258)		(24,258)
Balance, September 30, 2023	8,268,639	$	1	$	315,574	$	(237,774)	$	77,801

	Voting Common Stock(1)			Additional Paid-in Capital		Accumulated Deficit		Total Stockholders' Equity
	Shares	Amount
Balance, December 31, 2021	6,641,914	$	9	$	169,916	$	(68,242)	$	101,683
Vesting of restricted stock units, net	9,298	—		—		—		—
Stock-based compensation	—	—		11,042		—		11,042
Net loss	—	—		—		(25,772)		(25,772)
Balance, March 31, 2022	6,651,212	9		180,958		(94,014)		$	86,953
Issuance of common stock for business combination	434,969	—		50,948		—		50,948
Issuance of common stock for debt modification	148,687	—		17,416		—		17,416
Issuance of common stock upon exercise of warrants	1	—		—		—		—
Vesting of restricted stock units, net	8,859	—		—		—		—
Stock-based compensation	—	—		11,783		—		11,783
Net loss	—	—		—		(31,663)		(31,663)
Balance, June 30, 2022	7,243,728	9		261,105		(125,677)		135,437
Vesting of restricted stock units, net	12,441	—		—		—		—
Stock-based compensation	—	—		11,013		—		11,013
Net loss	—	—		—		(27,104)		(27,104)
Balance, September 30, 2022	7,256,169	$	9	$	272,118	$	(152,781)	$	119,346

(1) Share amounts have been retroactively adjusted to reflect the Reverse Stock Split (as defined below). See Note 2, Summary of Significant Accounting Policies, for additional detail.

See accompanying Notes to Unaudited Condensed Consolidated Financial Statements

7

LOCAL BOUNTI CORPORATION

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

	Nine Months Ended September 30,
	2023		2022
Operating Activities:
Net loss	$	(58,461)	$	(84,539)
Adjustments to reconcile net loss to cash used in operating activities:
Depreciation	5,152		3,477
Amortization	5,027		3,352
Stock-based compensation expense, net of amounts capitalized	13,658		33,616
Bad debt allowance	5		11
Inventory allowance	385		323
Loss on disposal of property and equipment	1,375		252
Gain related to change in fair value of warrant liability	(16,917)		—
Paid-in-kind interest	15,797		—
Amortization of debt issuance costs	5,183		2,791
Interest on financing obligation	144		333
Changes in operating assets and liabilities:
Accounts receivable	20		(68)
Inventory	(1,284)		2
Prepaid expenses and other current assets	1,291		976
Other assets	(649)		2,326
Accounts payable	(493)		5,114
Operating lease liabilities	(104)		6
Accrued liabilities	3,880		(4,849)
Net cash used in operating activities	(25,991)		(36,877)
Investing Activities:
Purchases of property and equipment	(117,241)		(40,863)
Asset acquisition	—		(25,813)
Business combination, net of cash acquired	—		(90,552)
Net cash used in investing activities	(117,241)		(157,228)
Financing Activities:
Proceeds from financing obligation	35,000		—
Proceeds from issuance of debt	101,861		119,351
Payment of debt issuance costs	(226)		(2,342)
Fractional shares paid in cash pursuant to Reverse Stock Split	(3)		—
Net cash provided by financing activities	136,632		117,009
Net decrease in cash and cash equivalents and restricted cash	(6,600)		(77,096)
Cash and cash equivalents and restricted cash and cash equivalents at beginning of period	24,938		101,077
Cash and cash equivalents and restricted cash and cash equivalents at end of period	$	18,338	$	23,981

8

Reconciliation of cash, cash equivalents, and restricted cash from the Unaudited Condensed Consolidated Balance Sheets to the Unaudited Condensed Consolidated Statements of Cash Flows

	Nine Months Ended September 30,
	2023		2022
Cash and cash equivalents	$	11,814	$	4,227
Restricted cash and cash equivalents	6,524		19,754
Total cash and cash equivalents and restricted cash and cash equivalents as shown in the Unaudited Condensed Consolidated Statements of Cash Flows	$	18,338	$	23,981

Non-cash activities:
Warrants issued in connection with debt modification	$	25,697	$	—
Purchases of property and equipment included in accounts payable and accrued liabilities	$	1,910	$	7,168
Non-cash equity settlement on employee receivable	$	176	$	17,416
Stock-based compensation capitalized to property and equipment, net	$	1,451	$	222
Interest capitalized to property and equipment, net	$	9,486	$	—
Non-cash financing obligation activity	$	—	$	840
Right-of-use asset obtained in exchange for operating lease liability	$	—	$	388
Reduction of right of use asset and associated lease liability due to lease cancellation	$	—	$	(203)

See accompanying Notes to Unaudited Condensed Consolidated Financial Statements

9

LOCAL BOUNTI CORPORATION

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

1. Business Description

Description of the Business

Local Bounti Corporation ("Local Bounti" or the "Company") was founded in August 2018 and is headquartered in Hamilton, Montana. The Company is a producer of sustainably grown living lettuce, herbs, and loose leaf lettuce. The Company is a controlled environment agriculture ("CEA") company that utilizes patent pending Stack & Flow TechnologyTM, which is a hybrid of vertical and hydroponic greenhouse farming, to grow healthy food sustainably and affordably. Through the Company's CEA process, its goal is to produce environmentally sustainable products in a manner that will increase harvest efficiency, limit water usage, and reduce the carbon footprint of the production and distribution process.

2. Summary of Significant Accounting Policies

Basis of Presentation and Principles of Consolidation

Management of Local Bounti is responsible for the Unaudited Condensed Consolidated Financial Statements included in this document, which have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP"). The Unaudited Condensed Consolidated Financial Statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in the statements herein.

The Unaudited Condensed Consolidated Financial Statements do not include all of the disclosures required by GAAP for annual financial statements and should be read in conjunction with the audited Consolidated Financial Statements of the Company for the year ended December 31, 2022 (the "Annual Financial Statements") as filed with the SEC on March 31, 2023. In the opinion of the Company, the accompanying Unaudited Condensed Financial Statements contain all adjustments, consisting of only normal recurring adjustments, necessary to fairly present its financial position as of September 30, 2023, its results of operations for the three and nine months ended September 30, 2023 and 2022, its cash flows for the nine months ended September 30, 2023 and 2022, and its stockholders' equity for the three and nine months ended September 30, 2023 and 2022. Results of operations for the interim periods are not necessarily indicative of the results to be expected for the full year ending December 31, 2023 or any future period. The Unaudited Condensed Consolidated Balance Sheet at December 31, 2022 was derived from the Annual Financial Statements but does not contain all of the footnote disclosures from the Annual Financial Statements.

Liquidity

The Company has incurred losses and generated negative cash flows from operations since its inception. At September 30, 2023, the Company had an accumulated deficit of $237.8 million and cash and cash equivalents and restricted cash of $18.3 million.

Cargill Financial expects to provide the Company with $10 million of working capital subject to certain terms and conditions precedent. The Company anticipates closing this transaction in the fourth quarter of this year. The Company has also executed conditional commitment letters from a commercial finance lender for total potential financing of up to approximately $230 million at a floating interest rate of Secured Overnight Financing Rate ("SOFR") plus a margin of 345 basis points per annum (equivalent to approximately 8.8% as of the filing date of this 10-Q Report) in order to fund its 2024 greenfield build and facility expansions. The Company expects to execute definitive documents for such financings in the first quarter of 2024, subject to negotiation of final terms and underwriting commitments.

The Company believes that the additional $10 million of working capital from Cargill Financial, the $230 million from a commercial finance lender, the Company's current cash position, cash generated from product sales, and anticipated cash interest payment deferrals under the Company's credit facilities with Cargill Financial will be adequate to fund the Company’s planned operations over the next 12 months from the issuance of these Unaudited Condensed Consolidated Financial Statements.

The Company also believes additional cash can be secured through other debt or equity financings, if necessary. However, there can be no assurance that equity or debt financing will be available to the Company should it need it or, if available, that the terms will be satisfactory to the Company and not dilutive to existing shareholders. The Company's failure to raise capital as and when needed could have significant negative consequences for its business, financial condition and results of consolidated operations.

Reverse Stock Split Stockholder Approval

On April 3, 2023, the Company's board of directors (the "Board") authorized an amendment to the Company's Certificate of Incorporation to, at the discretion of the Board, effect a reverse stock split of the shares of Local Bounti's common stock, at any time prior to June 30, 2024, at a ratio within a range of 1-for-2 to 1-for-25, with the exact ratio and effective time of the reverse stock split to be determined at the discretion of the Board without further approval or

10

authorization of the Company's stockholders. The amendment was approved by stockholders at a special meeting of stockholders held on April 26, 2023. On June 4, 2023, the Board approved a 1-for-13 reverse stock split (the "Reverse Stock Split") of the Company's issued and outstanding shares of common stock, par value $0.0001 per share. Trading of the Company's common stock on the NYSE commenced on a split-adjusted basis on June 15, 2023.

As a result of the Reverse Stock Split, every 13 shares of common stock issued and outstanding were automatically reclassified into one new share of common stock without any action on the part of the holders. The Company paid cash in lieu of fractional shares resulting from the Reverse Stock Split. Proportionate adjustments were made to the exercise prices and the number of shares underlying the Company’s outstanding equity awards, as applicable, and warrants exercisable for shares of Common Stock, as well as to the number of shares issuable under the Company’s equity incentive plans and certain existing agreements. Also, for the Company’s outstanding warrants to purchase up to 81,139,179 shares of common stock, every 13 shares issuable under warrants became exercisable for one share of common stock at an exercise price of $149.50 per share of common stock for the Company's publicly traded warrants and $13.00 per share of common stock for the March 2023 Cargill Warrant. See Note 9, Stock-Based Compensation, and Note 10, Net Loss Per Share, for more information. The common stock issued pursuant to the Reverse Stock Split will remain fully paid and non-assessable. The Reverse Stock Split did not affect the number of authorized shares of common stock or the par value of the common stock.

All share and per share amounts presented herein with respect to common stock have been retroactively adjusted to reflect the Reverse Stock Split for all periods presented.

There have been no material changes or updates to the Company's significant accounting policies from those described in the Annual Financial Statements except for the updates noted below.

Derivatives

Equity instruments issued in connection with debt and other equity instruments are required to be evaluated for derivative liability accounting treatment in accordance with Accounting Standards Codification ("ASC") 815, Derivatives and Hedging. Unless certain exception criteria are met, the freestanding financial instrument or embedded feature must be recognized as a separate liability and subsequently measured on the balance sheet at fair value in accordance with ASC 820, Fair Value Measurement.

The Company has evaluated the terms and features of its debt and equity instruments and identified a freestanding equity instrument (the March 2023 Cargill Warrant) issued in connection with the Sixth Amendment that did not meet the criteria necessary to qualify for the derivative scope exception. See Note 6, Debt, and Note 8, Fair Value Measurements, for more information related to the Sixth Amendment and the March 2023 Cargill Warrant, respectively. Due to certain provisions that could result in the issuance of additional shares upon settlement, the warrant instrument did not meet the fixed-for-fixed criteria necessary for the instrument to be classified and recorded within equity. As a result, the warrant is accounted for at fair value until settled through exercise or expiration and is classified as a derivative liability in the Unaudited Condensed Consolidated Balance Sheet at September 30, 2023. The initial $25.7 million fair value of the March 2023 Cargill Warrant was recorded as additional debt discount to the Facilities (as defined below) and a derivative liability in the "Warrant Liability" line item of the Unaudited Condensed Consolidated Balance Sheets. The change in fair value of the warrant will be remeasured each quarter until the instrument is settled or expires with changes in fair value recorded in "Change in fair value of warrant liability" in the Unaudited Condensed Consolidated Statements of Operations. The fair value of the warrant liability is determined using a Black-Scholes-Merton option pricing model. See Note 6, Debt, for more information.

Recently Adopted Accounting Pronouncements

In June 2016, the FASB issued ASU 2016-13, Financial Instruments-Credit Losses (Topic 326), which amends the guidance on reporting credit losses for assets held at amortized cost and available for sale debt securities. For assets held at amortized cost, the amendment eliminates the probable initial recognition threshold in current GAAP and, instead, requires an entity to reflect its current estimate of all expected credit losses. The allowance for credit losses is a valuation account that is deducted from the amortized cost of the financial assets to present the net amount expected to be collected. The Company adopted this guidance on January 1, 2023 using the modified retrospective method. The adoption of this guidance did not have a material impact on the Company's Unaudited Condensed Consolidated Financial Statements.

11

Recently Issued Accounting Pronouncements

In August 2020, the FASB issued ASU 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity's Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity, which simplifies the accounting for certain financial instruments with characteristics of liability and equity, including convertible instruments and contracts on an entity’s own equity. The standard reduces the number of models used to account for convertible instruments, removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, and requires the if-converted method for calculation of diluted earnings per share for all convertible instruments. The standard is effective for the Company for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2023. Early adoption is permitted. The Company is currently evaluating the impact of this standard on its Consolidated Financial Statements.

3. Inventory

Inventory consisted of the following:

	September 30,		December 31,
	2023		2022
	(in thousands)
Raw materials	$	2,640	$	2,018
Production(1)	2,660		2,213
Finished goods(1)	269		54
Inventory allowance	(1,076)		(691)
Total inventory, net	$	4,493	$	3,594

_____________________

(1) Approximately $1.8 million of inventory classified as finished goods at December 31, 2022 has been reclassified to the production category at September 30, 2023 to conform the historical presentation to the current period presentation, which reflects the nature and timing of the Company's current harvesting and cost accumulation processes.

4. Property and Equipment

Property and equipment consisted of the following:

	September 30,		December 31,
	2023		2022
	(in thousands)
Machinery, equipment, and vehicles	$	41,528	$	32,774
Land	19,253		19,296
Buildings and leasehold improvements	63,659		55,392
Construction-in-progress	155,073		56,753
Less: Accumulated depreciation	(11,414)		(6,371)
Property and equipment, net	$	268,099	$	157,844

Depreciation expense related to property and equipment was $1.7 million and $1.7 million for the three months ended September 30, 2023 and 2022, respectively, and $5.2 million and $3.5 million for the nine months ended September 30, 2023 and 2022, respectively.

12

5. Accrued Liabilities

Accrued liabilities consisted of the following:

	September 30,		December 31,
	2023		2022
	(in thousands)
Interest	$	8,115	$	4,372
Construction	3,104		825
Payroll	1,469		1,470
Production	1,426		1,438
Professional services	322		894
Other	1,185		427
Total accrued liabilities	$	15,621	$	9,426

6. Debt

Debt consisted of the following:

	September 30,		December 31,
	2023		2022
	(in thousands)
Senior Facility	$	211,927	$	98,442
Subordinated Facility	46,673		42,500
Unamortized deferred financing costs	(41,642)		(21,128)
Total debt	$	216,958	$	119,814

Agreements with Cargill Financial

As previously disclosed in the Company's Annual Financial Statements, Local Bounti Operating Company LLC ("Local Bounti Operating"), the Company and certain subsidiaries entered into with Cargill Financial a First Amendment, a Second Amendment, and a Third Amendment to the Credit Agreement, dated as of September 3, 2021, and the Subordinated Credit Agreement, dated as of September 3, 2021 (the "Original Credit Agreements," and the facilities thereunder, the "Senior Facility" and the "Subordinated Facility," respectively and, collectively, the "Facilities") (which are further described in the Annual Financial Statements) in March 2022, August 2022, and December 2022, respectively. As further described below, Local Bounti Operating, the Company, and certain subsidiaries entered into with Cargill Financial a Fourth Amendment, a Fifth Amendment, and a Sixth Amendment to the Original Credit Agreements (as so amended, collectively referred to as the "Amended Credit Agreements").

Fourth Amendment to the Original Credit Agreements

On January 6, 2023, Local Bounti Operating, the Company and certain subsidiaries entered into a Fourth Amendment to the Original Credit Agreements (the "Fourth Amendment") with Cargill Financial. The Fourth Amendment reduced the minimum liquidity covenant in each of the Original Credit Agreements from $20.0 million to $11.0 million.

Fifth Amendment to the Original Credit Agreements

On March 13, 2023, Local Bounti Operating, the Company and certain subsidiaries entered into a Fifth Amendment to the Original Credit Agreements (the "Fifth Amendment") with Cargill Financial. The Fifth Amendment (i) reduced the amount of cash required to be held in the debt service reserve account by approximately $11.0 million until April 2, 2024, at which time the amount of cash required to be held in the debt service reserve account will be an amount equal to the sum of interest and principal payments that would be required under the Amended Credit Agreements for two calendar quarters; (ii) allowed for the payment in kind of the quarterly interest payment due and payable for the quarter ended March 31, 2023 and allowed for the payment in kind of the unused commitment fee payable for the quarter ended March 31, 2023 which amounted to $4.3 million; and (iii) reduced the minimum liquidity covenant in each of the Amended Credit Agreements from $11.0 million to $1.0 million. The aggregate amount of outstanding loans and undrawn commitments under the Amended Credit Agreements remained at $170.0 million (plus interest and fees paid in kind).

Sixth Amendment to the Original Credit Agreements

On March 28, 2023, Local Bounti Operating, the Company and certain subsidiaries entered into a Sixth Amendment to the Original Credit Agreements (the "Sixth Amendment") with Cargill Financial. The Sixth

13

Amendment, among other things, (i) expanded the Facilities from $170.0 million to up to $280.0 million (plus, in each case, interest and fees paid in kind), including capital to fund construction at the Company’s facilities in Georgia, Texas, and Washington, subject to certain conditions and at Cargill Financial's discretion; (ii) allowed for the payment in kind of the quarterly interest payment due and payable for the quarter ending June 30, 2023 which amounted to $5.0 million; and (iii) added a minimum production covenant based on a projected production forecast. In consideration for the improved flexibility and the expanded size of the Facilities, Local Bounti issued Cargill Financial 5.4 million warrants with a per share exercise price of $13.00 per share (both number of warrants and per share exercise price adjusted for the Reverse Stock Split) and a 5-year term that expires on March 28, 2028 (the "March 2023 Cargill Warrant").

The Company evaluated the before and after cash flow changes resulting from the Fourth, Fifth and Sixth Amendments and concluded the change in cash flows underlying these cumulative amendments were not significantly different from the cash flows underlying the terms in the Original Credit Agreements; therefore, the Company accounted for these amendments as a modification rather than as an extinguishment. Consequently, the $25.7 million fair value of the March 2023 Cargill Warrant was recorded as an additional debt discount that will amortize to interest expense over the remaining term of the Amended Credit Agreements. Fees paid to non-lender third parties as a result of the modification have been expensed as incurred.

Subsequent to the Sixth Amendment, the interest rate on the Subordinated Facility is 12.5% per annum and the interest rate on the Senior Facility is equal to SOFR plus a margin (which varies between 7.5% to 8.5% depending on the Senior Facility net leverage ratio) per annum, with accrued interest paid quarterly in arrears on the first business day of the subsequent quarter through the maturity date on September 3, 2028. Principal payments under the Senior Facility are payable quarterly, beginning April 1, 2025, based on a 10-year straight line amortization schedule, with the remaining unpaid balance under both the Senior Facility and the Subordinated Facility due on the September 3, 2028 maturity date.

In accordance with the Original Credit Agreements, the Company is required to have a debt service reserve account which is shown as restricted cash and cash equivalents on the Unaudited Condensed Consolidated Balance Sheets. The Fifth Amendment and Sixth Amendment, taken together, reduced the minimum balance to maintain in the debt service reserve account to $0 through March 31, 2025. From and after April 1, 2025, the minimum balance to maintain in the debt service reserve account will be increased to two quarters of scheduled interest payments and two quarters of scheduled principal payments.

The Amended Credit Agreements also contain certain financial covenants that become measurable and effective beginning in the third quarter of 2025, including debt coverage, net leverage, and interest coverage ratios. Additional covenants and other provisions exist that may limit or affect the timing of the Company's ability, among other things, to undergo a merger or consolidation, sell certain assets, create liens, guarantee certain obligations of third parties, make certain investments or acquisitions, and declare dividends or make distributions. The Facilities are secured with a first-priority lien against substantially all of the assets of the Company and its subsidiaries, including their intellectual property. The Company was in compliance with all applicable covenants as of September 30, 2023 other than the financial covenant set forth in Section 6.8(g) of the Amended Credit Agreements. On October 31, 2023, the Company, along with certain subsidiaries of the Company, entered into the Limited Covenant Waiver with Cargill Financial pursuant to which Cargill Financial waived the financial covenant set forth in Section 6.8(g) of the Amended Credit Agreements for the calendar quarter ended September 30, 2023.

7. Financing Obligation

On April 27, 2023, Hollandia Real Estate, LLC ("Hollandia"), a wholly-owned subsidiary of the Company, and STORE Master Funding XXXI, LLC ("STORE") consummated a $35 million multi-site sale and leaseback transaction relating to the Carpinteria Facility and the Oxnard Facility (collectively, the "Hollandia Facilities").

In connection with the sale and leaseback transaction, Hollandia and STORE entered into a Master Lease Agreement (the "STORE Lease"), dated April 27, 2023 (the "Effective Date"). Pursuant to the STORE Lease, Hollandia will lease the Hollandia Facilities from STORE, subject to the terms and conditions of the STORE Lease.

The STORE Lease provides for an initial term of 25 years, commencing on the Effective Date and expiring on April 30, 2048 ("Initial Term"). Hollandia has four options to extend the Initial Term for separate renewal terms of five years each (together with the Initial Term, the "Lease Term"). Subject to adjustment as set forth in the STORE Lease, the combined annual minimum rent payable to STORE during the first year of the Lease Term is an amount equal to $3.2 million (the "Base Annual Rent") with payments made monthly, subject to annual rent increases of three percent (3%) of the Base Annual Rent.

The STORE Lease contains certain representations, warranties, covenants, obligations, conditions, indemnification provisions and termination provisions customary for sale and leaseback transactions.

As part of the STORE Lease, Hollandia delivered to STORE a letter of credit in an amount equal to $6.5 million as security for the full and faithful performance by Hollandia of the terms, provisions, covenants and conditions of the STORE Lease. In the event of default under the Lease, STORE shall have the right to draw on the letter of credit to satisfy any monetary obligations under the STORE Lease. The letter of credit shall be released after five (5) years, contingent on achieving certain financial metrics as specified in the STORE Lease. The $6.5 million for the letter of credit is included in "Restricted cash" on the Unaudited Condensed Consolidated Balance Sheets.

14

The Company accounted for the STORE Lease as a financing transaction in accordance with ASC 842, Leases, as the STORE Lease was determined to be a finance lease. The presence of a finance lease indicates that control of the Hollandia Facilities has not transferred to STORE and, as such, the transaction was deemed a failed sale and leaseback and the proceeds from the sale and leaseback transaction are therefore accounted for as a financing obligation. The leased assets remain on the Unaudited Condensed Consolidated Balance Sheets and will continue to be depreciated over their original estimated useful lives, and the contractual lease payments will be allocated between interest expense (as imputed interest) and repayment of the $35 million financing obligation through April 30, 2048, which is the end of the 25-year lease term and when the Company expects control of the leased assets to transfer to STORE. The Company utilized a rate of 11.06% to calculate imputed interest and recognized $0.7 million and $1.7 million of interest expense for the three and nine months ended September 30, 2023 related to the STORE Lease.

The following table summarizes future financing obligation payments for the Initial Term by fiscal year through April 30, 2048, when control of the leased assets is expected to transfer to STORE:

	STORE Lease Financing Obligation
	(in thousands)
Remainder of 2023	$	809
2024	3,302
2025	3,401
2026	3,503
2027	3,608
Thereafter	102,063
Total financing obligation payments	116,686
Unamortized deferred financing costs	(222)
Amount representing interest	(96,645)
Net financing obligation and asset at end of term	15,239
Total financing obligation	$	35,058

8. Fair Value Measurements

The following table sets forth, by level within the fair value hierarchy, the accounting of the Company’s financial assets and liabilities at fair value on a recurring and nonrecurring basis according to the valuation techniques the Company uses to determine their fair value:

	September 30, 2023
	Level 1		Level 2		Level 3
	(in thousands)
Recurring fair value measurements
Assets:
Money market funds	$	18,231	$	—	$	—
Liabilities:
March 2023 Cargill Warrant Liability	$	—	$	—	$	8,780

	December 31, 2022
	Level 1		Level 2		Level 3
	(in thousands)
Recurring fair value measurements
Assets:
Money market funds	$	13,997	$	—	$	—

The fair value of the Company's money market funds is determined using quoted market prices in active markets for identical assets.

15

The fair value of the March 2023 Cargill Warrant Liability is determined using a Black-Scholes-Merton option pricing model. The following table presents changes in the Level 3 fair value measurement for the warrant liability on a recurring basis:

	September 30,
	2023
	(in thousands)
Balance as of March 28, 2023 (initial measurement)	$	25,697
Fair value measurement adjustments	(15,151)
Balance as of June 30, 2023	10,546
Fair value measurement adjustments	(1,766)
Balance as of September 30, 2023	$	8,780

The key inputs into the Black-Scholes-Merton option pricing model used to determine the fair value of the 2023 Cargill Warrant Liability were as follows at their measurement dates:

	September 30, 2023		March 28, 2023 (initial measurement)
Input
Share price	$	2.45	$	5.84
Risk-free interest rate	4.60%		3.63%
Volatility	128%		135%
Exercise price	$	13.00	$	13.00
Warrant life (years)	4.5		5.0
Dividend yield	—%		—%

As of September 30, 2023 and December 31, 2022, the carrying value of the Company's cash and cash equivalents, restricted cash, accounts receivable, accounts payable and accrued expenses approximated their respective fair values due to their short-term maturities. There were no transfers of financial instruments between Level 1, Level 2, and Level 3 during the periods presented.

16

9. Stock-Based Compensation

Restricted Common Stock Awards

A summary of the restricted common stock awards ("RSAs") for the nine months ended September 30, 2023 is as follows:

	Number of Shares of Restricted Common Stock Awards1	Average Grant-Date Fair Value1
Unvested at December 31, 2022	288,804	$	24.05
Forfeited	(19,175)	$	36.27
Vested	(46,937)	$	34.19
Unvested at September 30, 2023	222,692	$	20.83

_____________________

(1) Share and per share amounts have been retroactively adjusted to reflect the Reverse Stock Split. See Note 2, Summary of Significant Accounting Policies, for additional detail.

Total expense of RSAs for the three and nine months ended September 30, 2023 was $0.3 million and $0.9 million, respectively. Total expense of RSAs for the three and nine months ended September 30, 2022 was $1.8 million and $3.6 million, respectively. As of September 30, 2023, the total compensation cost related to unvested RSAs not yet recognized is $1.0 million. Unvested RSA expense not yet recognized is expected to be recognized over a weighted average period of 1.12 years.

Restricted Stock Units

A summary of the restricted stock units ("RSUs") activity for the nine months ended September 30, 2023 is as follows:

	Number of RSUs(1)	Average Grant-Date Fair Value(1)
Unvested at December 31, 2022	727,484	$	81.51
Granted	815,620	$	8.62
Forfeited	(59,648)	$	73.98
Vested	(386,141)	$	66.10
Vested, unsettled	42,289	$	73.33
Unvested and outstanding at September 30, 2023	1,139,604	$	34.65

_____________________

(1) Share and per share amounts have been retroactively adjusted to reflect the Reverse Stock Split. See Note 2, Summary of Significant Accounting Policies, for additional detail.

Total expense of RSUs, net of amounts capitalized, for the three and nine months ended September 30, 2023 was $2.9 million and $12.8 million, respectively. Total expense of RSUs for the three and nine months ended September 30, 2022 was $9.1 million and $30.0 million, respectively. As of September 30, 2023, the total compensation cost related to unvested RSUs not yet recognized is $13.9 million. Unvested RSU expense not yet recognized is expected to be recognized over a weighted average period of 2.04 years.

10. Net Loss Per Share

Net loss per share is computed by dividing net loss by the weighted average number of common stock outstanding during the period. In computing net loss per share, the Company's unvested restricted common stock and warrants are not considered participating securities. Diluted loss per common share is the same as basic loss per common share for the three and nine months ended September 30, 2023 and 2022 because the effects of potentially dilutive items were anti-dilutive given the Company's net loss. Diluted net loss per common share represents an adjustment to basic net loss per share attributable to common stockholders giving effect to all potential common shares that were dilutive and outstanding during the period.

17

The following table sets forth the computation of the Company's net loss per share attributable to common stockholders:

	Three Months Ended September 30,				Nine Months Ended September 30,
	(in thousands, except share and per share data)(1)
	2023		2022		2023		2022
Net loss	$	(24,258)	$	(27,104)	$	(58,461)	$	(84,539)
Weighted average common stock outstanding, basic and diluted	8,019,561		6,865,001		7,893,665		6,639,879
Net loss per common share, basic and diluted	$	(3.02)	$	(3.95)	$	(7.41)	$	(12.73)

_____________________

(1) Share and per share amounts have been retroactively adjusted to reflect the Reverse Stock Split. See Note 2, Summary of Significant Accounting Policies, for additional detail.

The following table discloses the weighted-average shares outstanding of securities that could potentially dilute basic net earnings per share in the future that were not included in the computation of diluted net loss per share as the impact would be anti-dilutive:

	Three Months Ended September 30,		Nine Months Ended September 30,
	2023	2022	2023	2022
Restricted Stock(1)	222,692	385,465	230,632	401,876
Warrants(2)	6,241,475	887,629	4,554,915	887,625

_____________________

(1) Share amounts have been retroactively adjusted to reflect the Reverse Stock Split. See Note 2, Summary of Significant Accounting Policies, for additional detail.

(2) Subsequent to the Reverse Stock Split, every 13 common shares under warrants becomes exercisable for one share of common stock at an exercise price of $149.50 per share of common stock for the Company's publicly traded warrants and $13.00 per share of common stock for the March 2023 Cargill Warrant, which is reflected in the table above. See Note 2, Summary of Significant Accounting Policies, for additional detail.

11. Commitments and Contingencies

Legal Matters

The Company has and may become party to various legal proceedings and other claims that arise in the ordinary course of business. The Company records a liability when it believes that it is probable that a loss will be incurred, and the amount of loss or range of loss can be reasonably estimated. Management is currently not aware of any matters that it expects will have a material adverse effect on the financial position, results of operations, or cash flows of the Company.

12. Subsequent Events

Seventh Amendment to Credit Agreements

On October 2, 2023, the Company, along with certain subsidiaries of the Company, entered into a Seventh Amendment to the Original Credit Agreements (the "Seventh Amendment") with Cargill Financial to further amend the Original Credit Agreements. The Seventh Amendment allows for the payment in kind of the quarterly interest payments due and payable for the quarters ending September 30, 2023 and December 31, 2023.

18

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

The following discussion should be read in conjunction with our Unaudited Condensed Consolidated Financial Statements, including the Notes to those statements, included elsewhere in this Quarterly Report on Form 10-Q, and the section entitled "Cautionary Note Regarding Forward-Looking Statements" in this Quarterly Report on Form 10-Q. As discussed in more detail in the section entitled "Cautionary Note Regarding Forward-Looking Statements," this discussion contains forward-looking statements, which involve risks and uncertainties. Our actual results may differ materially from the results discussed in the forward-looking statements.

Our Mission and Vision

Our mission is to bring our farm to your kitchen. Our vision is to deliver the freshest, locally grown produce over the fewest food miles. We believe that happy plants make happy taste buds and we are committed to reimagining the standards of freshness. We also believe that local is the best kind of business, and we are committed to helping communities thrive for generations to come. We are committed to building empowered local teams. Together, we believe we are capable of extraordinary things.

Company Overview

Local Bounti is a controlled environment agriculture ("CEA") company that produces sustainably grown produce, focused today on living and loose leaf lettuce. Founded in 2018, and headquartered in Hamilton, Montana, Local Bounti utilizes its patent pending Stack & Flow Technology™ to grow healthy food sustainably and affordably. Our proprietary process is a hybrid, utilizing vertical farming in early plant growth, followed by greenhouse farming for final grow out. We designed our Stack & Flow Technology™ to give our products exactly what they need at every step of their growth cycle. Our goal is to grow in an environmentally sustainable manner that not only increases harvest efficiency and enhances unit economics, but also limits water usage and reduces the carbon footprint of the production and distribution process. Controlling the environmental conditions in both the 'Stack' and 'Flow' components of our growing system helps to ensure healthy, nutritious, consistent, and delicious products that are non-genetically modified organisms ("non-GMO"). We use 90% less water, 90% less land, and significantly less pesticides and herbicides than traditional outdoor agriculture operations.

Our first facility in Hamilton, Montana (the "Montana Facility") commenced construction in 2019 and reached full commercial operation by the second half of 2020. In 2021, we successfully completed the expansion of our Montana Facility, more than doubling our production capacity. Immediately after expansion, this facility was dedicated equally to commercial production and research and development that focused on new products, technology and system design. Today, the majority of the Montana Facility is dedicated to commercial production, but we continue to utilize dedicated space for research and development to improve our existing and future facilities.

On April 4, 2022, Local Bounti acquired California-based complementary greenhouse farming company Hollandia Produce Group, Inc. and its subsidiaries (the "Pete's Acquisition"), which operate under the name Pete's ("Pete's"). Through the Pete's Acquisition, we significantly increased our growing footprint, now operating three additional greenhouse growing facilities, including two in California and one in Georgia, the latter of which became operational in July 2022. We now have distribution to approximately 13,000 retail locations across 35 U.S. states and Canadian provinces, primarily through direct relationships with blue-chip retail customers, including Albertsons, Sam's Club, Kroger, Target, Walmart, Whole Foods, and AmazonFresh. Today, our primary product is living butter lettuce – for which we are a leading provider with an approximate 80% share of the CEA market within the Western U.S.

We derive the majority of our revenue from the sale of produce. We grow and package fresh greens that are sold into existing markets and channels such as food retailers and food service distributors from our Montana and two California facilities, and beginning in the third quarter of 2022, from our Georgia facility.

We offer sales incentives to our customers, including temporary price reductions. We anticipate that these promotional activities could impact sales and that changes in such activities could impact period-over-period results. Sales may also vary from period to period depending on the purchase orders we receive, the volume and mix of products sold and the channels through which our products are sold. In response to realized cost inflation, we have implemented contractually allowable price increases which we anticipate to benefit from in 2023 and beyond.

We intend to increase our production capacity and expand our reach to new markets, new geographies, and new customers through either the building of new facilities or through the acquisition of existing greenhouse facilities which we would plan to update with our Stack & Flow Technology™. We conduct an ongoing build-versus-buy analysis whenever we decide to build a new facility or acquire an existing facility. We also expect to expand our product offering to new varieties of fresh greens, herbs, berries, and other produce. Additionally, we evaluate commercial opportunities as part of these expansion efforts on an ongoing basis.

In October 2022, we signed a five-year offtake agreement with Sam's Club for our leafy greens production starting at our greenhouse facility in Georgia. We continue to advance our expansion of the Georgia facility and further

19

enhance capacity with the addition of our Stack & Flow TechnologyTM to meet pent up demand for Local Bounti packaged salads to current customers and open the opportunity to earn new business in that region.

Commercial Facility Expansion Update

Byron, Georgia Facility Progress

We finished the integration of the Stack zones that comprise Phase 1-C in early October 2023. With this project reaching completion, our Stack & Flow TechnologyTM system is now fully functional. During the integration process, we also took the opportunity to redesign our workflows and optimize our operations to account for the larger footprint (expanded from three to six acres of greenhouse) and the 40% greater capacity that is being generated by the Stack system.

Mount Pleasant, Texas Facility Progress

We began installation of the Stack zones and greenhouse growing systems in the third quarter of 2023 and continue to expect operations to commence later in the fourth quarter of 2023. The addition of this new facility in northeast Texas is expected to fortify our distribution in markets across Texas, Oklahoma, Louisiana, Mississippi, Arkansas, Kansas, and Missouri. Further, the facility is designed to provide additional capacity to meet existing demand from our direct relationships with blue-chip retailers and distributors throughout the region.

Pasco, Washington Facility Progress

The greenhouse structure is now complete and overhead and underground infrastructure work is progressing. When complete, the facility will be comprised of three acres of greenhouse that will be supported by multiple Stack zones. The facility will help bolster our distribution capabilities in the Pacific Northwest and is still expected to commence operations early in the first quarter 2024, which reflects our decision to stagger construction to accommodate the commissioning of our Texas facility in the fourth quarter of 2023.

Recent Developments

We have also executed conditional commitment letters from a commercial finance lender for total potential financing of up to approximately $230 million at a floating interest rate of SOFR plus a margin of 345 basis points per annum (equivalent to approximately 8.8% as of the filing date of this 10-Q Report) in order to fund our 2024 greenfield build and facility expansions. We expect to execute definitive documents for such financings in the first quarter of 2024, subject to negotiation of final terms and underwriting commitments.

Factors Affecting Our Financial Condition and Results of Operations

We expect to expend substantial resources as we:

•complete construction and commissioning of new facilities in Pasco, Washington, and Mount Pleasant, Texas;

•standardize operating and manufacturing processes across our facilities and continued integration of Pete's operations into our business;

•identify and invest in future growth opportunities, including new product lines;

•invest in product innovation and development;

•invest in sales and marketing efforts to increase brand awareness, engage customers and drive sales of our products; and

•incur additional general administration expenses, including increased executive, finance, legal and accounting expenses associated with being a public company, and growing operations.

20

Results of Operations

Three and Nine Months Ended September 30, 2023 compared to the Three and Nine Months Ended September 30, 2022

The following table sets forth our historical operating results for the periods indicated:

	Three Months Ended September 30,					Nine Months Ended September 30,
	2023		2022		$ Change	2023		2022		$ Change
	(in thousands)					(in thousands)
Sales	$	6,810	$	6,285	525	$	20,691	$	12,836	7,855
Cost of goods sold(1)(2)(3)	6,405		5,015		1,390	19,155		11,535		7,620
Gross profit	405		1,270		(865)	1,536		1,301		235
Operating expenses:
Research and development(2)(3)	5,001		3,019		1,982	12,103		8,933		3,170
Selling, general and administrative(2)(3)	14,406		20,239		(5,833)	47,091		64,741		(17,650)
Total operating expenses	19,407		23,258		(3,851)	59,194		73,674		(14,480)
Loss from operations	(19,002)		(21,988)		2,986	(57,658)		(72,373)		14,715
Other income (expense):
Change in fair value of warrant liability	1,766		—		1,766	16,917		—		16,917
Interest expense, net	(7,105)		(5,154)		(1,951)	(17,876)		(12,262)		(5,614)
Other income	83		38		45	156		96		60
Net loss	$	(24,258)	$	(27,104)	2,846	$	(58,461)	$	(84,539)	26,078

(1) Amounts include the impact for non-cash increase in cost of goods sold attributable to the fair value basis adjustment to inventory in connection with the Pete's Acquisition as follows:

	Three Months Ended September 30,					Nine Months Ended September 30,
	2023		2022		$ Change	2023		2022		$ Change
Cost of goods sold	$	—	$	—	—	$	—	$	1,042	(1,042)
Total business combination fair value basis adjustment to inventory	$	—	$	—	—	$	—	$	1,042	(1,042)

(2) Amounts include stock-based compensation as follows:

	Three Months Ended September 30,					Nine Months Ended September 30,
	2023		2022		$ Change	2023		2022		$ Change
Cost of goods sold	$	24	$	29	(5)	$	100	$	81	19
Research and development	343		419		(76)	1,676		1,389		287
Selling, general and administrative	2,898		10,459		(7,561)	11,882		32,146		(20,264)
Total stock-based compensation expense, net of amounts capitalized	$	3,265	$	10,907	(7,642)	$	13,658	$	33,616	(19,958)

(3) Amounts include depreciation and amortization as follows:

	Three Months Ended September 30,					Nine Months Ended September 30,
	2023		2022		$ Change	2023		2022		$ Change
Cost of goods sold	$	832	$	921	(89)	$	2,662	$	1,874	788
Research and development	722		229		493	1,754		760		994
Selling, general and administrative	1,851		1,757		94	5,763		4,195		1,568
Total depreciation and amortization	$	3,405	$	2,907	498	$	10,179	$	6,829	3,350

21

The following sections discuss and analyze the changes in the significant line items in our Unaudited Condensed Consolidated Statements of Operations for the comparative periods in the table above.

Sales

We derive the majority of our revenue from the sale of produce grown at our facilities. In response to realized cost inflation, we have implemented contractually allowable price increases which we anticipate to benefit from during the remainder of 2023 and beyond.

Sales increased by $0.5 million for the three months ended September 30, 2023, compared to the three months ended September 30, 2022. The increase was primarily due to an increase in sales from our Georgia facility, which became operational in July 2022, and also due to an increase in sales from our Montana Facility.

Sales increased by $7.9 million for the nine months ended September 30, 2023, compared to the nine months ended September 30, 2022. The increase was due primarily to the Pete's Acquisition at the beginning of April 2022 and to a lesser extent due to an increase in sales from our Georgia and Montana facilities.

Cost of Goods Sold

Cost of goods sold consists primarily of costs related to growing produce at our greenhouse facilities, including labor costs, which include wages, salaries, benefits, and stock-based compensation, seeds, soil, nutrients and other input supplies, packaging materials, depreciation, utilities and other manufacturing overhead. We expect that, over time, cost of goods sold will decrease as a percentage of sales, as a result of scaling our business.

Cost of goods sold increased by $1.4 million for the three months ended September 30, 2023 compared to the three months ended September 30, 2022, due primarily to increased production volume related to increased demand for our products during the three months ended September 30, 2023 compared to the three months ended September 30, 2022 and an increase in the cost of labor, utilities, and production supplies. Production volume and related gross margin was negatively impacted by weather-related variables at the Company's California facilities, which forced the temporary closure of a section of one of our facilities in the third quarter to repair damage, which have since been completed and the facility resumed normal production in October 2023. Production volume and related gross margin was also negatively impacted by lower utilization at our Georgia facility during the final implementation of vertical Stack towers.

Cost of goods sold increased by $7.6 million for the nine months ended September 30, 2023, compared to the nine months ended September 30, 2022, due primarily to the factors described above for the three months ended September 30, 2023 and by the Pete's Acquisition on April 4, 2022. We also experienced an increase of $0.7 million related to utilities price spikes in California and inclement weather-related costs that impacted yields at our California facilities during the first and second quarter of 2023, and an increase in the cost of labor, utilities, and production supplies. Also, cost of goods sold for the nine months ended September 30, 2022 was negatively impacted by the fair value step-up to expected selling price of acquired inventory from the Pete's Acquisition during the second quarter of 2022. This acquired inventory was subsequently sold during the second quarter of 2022 at the stepped-up value or at a zero margin, which negatively impacted gross margin during the second quarter of 2022 by $1.0 million.

Research and Development

Research and development expenses consist primarily of compensation to employees engaged in research and development activities, which include salaries, benefits, and stock-based compensation, overhead (including depreciation, utilities and other related allocated expenses), and supplies and services related to the development of our growing processes. Our research and development efforts are focused on the development of our processes utilizing our facilities, increasing production yields, developing new leafy green SKUs and value-added products such as grab-and-go salads, and exploring new crops, including berries. We focus our research and development efforts in areas we believe will generate future revenue and grow our intellectual property portfolio across process improvements, genetics, computer, vision, artificial intelligence, and process controls. We expect that, over the long term, research and development will decrease as a percentage of sales, as a result of the establishment of our growing process.

Research and development costs increased by $2.0 million for the three months ended September 30, 2023 compared to the three months ended September 30, 2022 and increased by $3.2 million for the nine months ended September 30, 2023, compared to the nine months ended September 30, 2022. The increase for both periods was due to increased investment in personnel, materials, supplies, and facility capacity usage for research and development purposes as we continue to expand our product offering and refine our growing process. We incurred costs for research and development of our production, harvesting, and post-harvest packaging techniques and processes, as well as production surplus costs related to the development and testing of our production processes.

Selling, General, and Administrative Expenses

Selling, general, and administrative expenses consist of employee compensation, including salaries, benefits, and stock-based compensation for our executive, legal, finance, information technology, human resources and sales and marketing teams, expenses for third-party professional services, Pete's Acquisition related integration costs, insurance, marketing, advertising, computer hardware and software, and amortization of intangible assets, among others.

22

Selling, general, and administrative expenses decreased by $5.8 million for the three months ended September 30, 2023, compared to the three months ended September 30, 2022, primarily driven by a $7.6 million decrease in stock-based compensation. Stock-based compensation decreased due to significantly higher fair value awards issued in prior periods becoming fully vested during the current period. The overall decrease in selling, general and administrative expenses was partially offset by an increase of $1.2 million related to loss on the disposal of fixed assets during the current period.

Selling, general, and administrative expenses decreased by $17.7 million for the nine months ended September 30, 2023, compared to the nine months ended September 30, 2022, primarily driven by a $20.3 million decrease in stock-based compensation and a $4.0 million decrease in transaction costs due primarily to the Pete's Acquisition in the prior year. Stock-based compensation decreased due to significantly higher fair value awards issued in prior periods becoming fully vested during the current period. The overall decrease in selling, general and administrative expenses was partially offset by an increase of $1.4 million in professional, legal, accounting, and consulting fees related to our strategic transactions and potential business acquisitions due diligence activities, an increase of $1.7 million in amortization of intangible assets acquired as part of the Pete's Acquisition, and an increase of $1.2 million in salaries, wages, and benefits due to increased headcount from Company growth and the Pete's Acquisition.

Change in Fair Value of Warrant Liability

The change in fair value of warrant liability includes the mark-to-market adjustments to the warrant liability to reflect its fair value as of the end of the reporting period. The decrease in fair value of the warrant liability is primarily due to the significant decrease in our closing stock price at September 30, 2023 compared to the closing stock price on the warrant issuance date. The period-end Local Bounti Corporation close stock price is a key input to the Black-Scholes-Merton option pricing model we use to measure and estimate the fair value of the warrant at the end of each reporting period.

Interest Expense, net

Interest expense consists primarily of contractual interest and amortization of debt issuance costs, net of interest capitalized for construction assets, related to the loans with Cargill Financial and also interest recognized per the terms of our financing obligation related to the Montana Facility and the Hollandia Facilities. We capitalize interest costs on borrowings during the construction period of major construction projects as part of the cost of the constructed assets.

Interest expense, net increased by $2.0 million for the three months ended September 30, 2023, compared to the three months ended September 30, 2022. The increase is primarily due to a $118.8 million increase in the principal amount outstanding on the Senior Facility as well as a variable rate increase on the Senior Facility period over period, which increased interest expense by $1.3 million over the prior year period. Also contributing to the net increase was $0.7 million of incremental interest expense related to the financing obligation for the Montana Facility and the Hollandia Facilities. We capitalized $4.2 million of interest related to the financing of our construction projects during the three months ended September 30, 2023. No such interest was capitalized during the three months ended September 30, 2022.

Interest expense, net increased by $5.6 million for the nine months ended September 30, 2023, compared to the nine months ended September 30, 2022. The increase is primarily due to a $118.8 million increase in the principal amount outstanding on the Senior Facility as well as a variable rate increase on the Senior Facility period over period, which increased interest expense by $5.1 million over the prior year period. Also contributing to the net increase was $1.4 million of incremental interest expense for the financing obligation related to the Montana Facility and the Hollandia Facilities. We capitalized $9.5 million of interest during the nine months ended September 30, 2023. No interest was capitalized during the nine months ended September 30, 2022.

23

Liquidity and Capital Resources

We have incurred losses and generated negative cash flows from operations since our inception. At September 30, 2023, we had an accumulated deficit of $237.8 million and cash and cash equivalents and restricted cash of $18.3 million.

Cargill Financial expects to provide us with $10 million of working capital subject to certain terms and conditions precedent. We anticipate closing this transaction in the fourth quarter of this year. We have also executed conditional commitment letters from a commercial finance lender for total potential financing of up to approximately $230 million at a floating interest rate of SOFR plus a margin of 345 basis points per annum (equivalent to approximately 8.8% as of the filing date of this 10-Q Report) in order to fund our 2024 greenfield build and facility expansions. We expect to execute definitive documents for such financings in the first quarter of 2024, subject to negotiation of final terms and underwriting commitments.

As of September 30, 2023, the principal amount due under our credit facilities with Cargill Financial totaled $258.6 million, none of which is classified as current. These debt agreements contain various financial and non-financial covenants and certain restrictions on our business, which include restrictions on additional indebtedness, minimum liquidity and other financial covenants, and material adverse effects, that could cause us to be at risk of default. A failure to comply with the covenants and other provisions of these debt instruments, including any failure to make payments when required, would generally result in events of default under such instruments, which could result in the acceleration of a substantial portion of such indebtedness.

The CEA business is capital-intensive. Currently, our primary sources of liquidity and capital resources are cash on hand, cash flows generated from the sale of our products, and the Facilities with Cargill Financial. Cash expenditures over the next 12 months are expected to include general operating costs for employee wages and related benefits, outside services for legal, accounting, IT infrastructure, and costs associated with growing, harvesting and selling our products, such as the purchase of seeds, soil, nutrients and other growing supplies, shipping and fulfillment costs, and facility maintenance costs.

We believe that the additional $10 million of working capital cash from Cargill Financial, the $230 million from a commercial finance lender, our current cash position, cash generated from product sales, and anticipated cash interest payment deferrals under our credit facilities with Cargill Financial will be adequate to fund our planned operations over the next 12 months from the issuance of these Unaudited Condensed Consolidated Financial Statements.

We also believe additional cash can be secured through other debt or equity financings, if necessary. However, there can be no assurance that equity or debt financing will be available to us should we need it or, if available, that the terms will be satisfactory to us and not dilutive to existing shareholders. Our future capital requirements and the adequacy of available funds will depend on many factors, including those set forth in Part I, Item 1A of the Company's most recent Annual Report on Form 10-K. Our failure to raise capital as and when needed could have significant negative consequences for its business, financial condition and results of consolidated operations.

Cargill Loans

In September 2021, the Company and Cargill Financial entered into the Senior Facility and the Subordinated Facility. Subsequent to the amendments described in Note 6, Debt, Cargill Financial may in its discretion provide advances under the Facilities of up to $280.0 million (plus interest and fees paid in kind), including capital to fund construction at the Company’s facilities in Georgia, Texas, and Washington, subject to certain conditions. As of September 30, 2023, a total of $211.9 million and $46.7 million was outstanding on the Senior Facility and the Subordinated Facility, respectively. The Senior Facility and the Subordinated Facility are included in "Long-term debt" on the Unaudited Condensed Consolidated Balance Sheets.

24

At September 30, 2023, our principal and estimated interest payment obligations for the Senior Facility and the Subordinated Facility are as follows(1):

(in thousands)
Remainder of 2023	$	—
2024	26,218
2025	51,696
2026	57,276
2027	57,276
Thereafter	240,519
Total	$	432,985

_____________________

(1)Interest is calculated based on a 12.5% interest rate for the Subordinated Facility and a 13.74% interest rate for the Senior Facility effective as of October 1, 2023.

Financing Obligations

We have a financing obligation related to a failed sale leaseback transaction for the Hollandia Facilities (see Note 7, Financing Obligation, to the Unaudited Condensed Consolidated Financial Statements for additional detail on this transaction) and a financing obligation related to a failed sale leaseback for the Montana Facility (see our most recent Annual Report on Form 10-K for additional detail on this transaction).

The following table summarizes future aggregate financing obligation payments by fiscal year for both the Hollandia Facilities and the Montana Facility:

	Financing Obligation
	(in thousands)
Remainder of 2023	$	1,204
2024	4,893
2025	5,024
2026	5,158
2027	5,297
Thereafter	126,971
Total financing obligation payments	148,547

Cash Flow Analysis

A summary of our cash flows from operating, investing, and financing activities is presented in the following table:

	Nine Months Ended September 30,
	2023		2022
	(in thousands)
Net cash used in operating activities	$	(25,991)	$	(36,877)
Net cash used in investing activities	(117,241)		(157,228)
Net cash provided by financing activities	136,632		117,009
Cash and cash equivalents and restricted cash at beginning of period	24,938		101,077
Cash and cash equivalents and restricted cash at end of period	$	18,338	$	23,981

Net Cash Used In Operating Activities

Net cash used in operating activities of $26.0 million for the nine months ended September 30, 2023 was driven by a net loss of $58.5 million. The net loss included a non-cash gain in fair value of warrant liability of $16.9 million. These amounts were partially offset by non-cash activities of $13.7 million in stock-based compensation expense, net of amounts capitalized, $15.8 million of paid-in-kind interest, $5.2 million in depreciation expense, $5.0 million in amortization expense, $5.2 million in amortization of debt issuance costs, and $2.7 million net increase of cash from changes in assets and liabilities.

25

Net cash used in operating activities of $36.9 million for the nine months ended September 30, 2022 was driven by a net loss of $84.5 million, partially offset by non-cash activities of $33.6 million in stock-based compensation expense, $2.8 million in amortization of debt issuance costs, $3.5 million in depreciation expense, $3.4 million in amortization expense, and $3.5 million net increase of cash from changes in assets and liabilities.

Net Cash Used In Investing Activities

Net cash used in investing activities was $117.2 million for the nine months ended September 30, 2023, due primarily to purchases of equipment and other items for the Washington, Georgia, and Texas facilities.

Net cash used in investing activities was $157.2 million for the nine months ended September 30, 2022, due primarily to the acquisitions in the prior year, including the Pete's Acquisition for net cash outlay of $90.6 million and a property acquisition for net cash outlay of $25.8 million. Additional cash used in investing activities related to $40.9 million of purchases of equipment and other items for the Washington, Georgia, and Montana facilities.

Net Cash Provided By Financing Activities

Net cash provided by financing activities was $136.6 million for the nine months ended September 30, 2023, comprised of $101.9 million of proceeds from the issuance of debt and $35.0 million of proceeds from the sale and leaseback transaction with STORE for the Hollandia Facilities. See Note 7, Financing Obligation, in Notes to the Unaudited Condensed Consolidated Financial Statements for additional detail on the sale and leaseback transaction.

Net cash provided by financing activities was $117.0 million for the nine months ended September 30, 2022, due primarily to $119.4 million of proceeds from the issuance of debt with Cargill Financial. This was partially offset by the payment of debt issuance costs of $2.3 million.

Critical Accounting Policies and Estimates

There have been no changes to the Company's critical accounting policies and estimates from those described under "Critical Accounting Policies and Estimates" in the Management's Discussion and Analysis of Financial Condition and Results of Operations of our Annual Report on Form 10-K for the year ended December 31, 2022, except as noted below and further discussed in Note 2 of the Unaudited Condensed Consolidated Financial Statements.

•The assessment and valuation of freestanding financial derivative instruments, which impacts gains or losses on such derivatives, the carrying value of debt, and interest expense.

Recent Accounting Pronouncements

For more information about recent accounting pronouncements, see Note 2 of the Unaudited Condensed Consolidated Financial Statements, which is incorporated into this Item 2 by reference thereto.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information under this item.

Item 4. Controls and Procedures

Limitations on effectiveness of control and procedures

In designing and evaluation our disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply judgment in evaluating the benefits of possible controls relative to their costs.

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated our disclosure controls and procedures, as such term is defined under Exchange Act Rule 13a-15(e) as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on this evaluation, our principal executive officer and principal financial officer concluded that, as of September 30, 2023, our disclosure controls and procedures were effective at the reasonable assurance level.

26

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the nine months ended September 30, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

27

PART II - OTHER INFORMATION

Item 1. Legal Proceedings

See Note 11, Commitments and Contingencies, to the Unaudited Condensed Consolidated Financial Statements for information regarding legal proceedings.

Item 1A. Risk Factors

There have been no material updates to our risk factors included in our Annual Report on Form 10-K for the year ended December 31, 2022, as updated by our Quarterly Report on Form 10-Q for the quarters ended March 31, 2023 and June 30, 2023, and Current Report on Form 8-K filed on October 30, 2023.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

There were no unregistered sales of our equity securities during the period covered by this quarterly report which were not previously reported in a Current Report on Form 8-K.

Item 5. Other Information

Share Repurchase Program

On October 29, 2023, the Company's Board of Directors authorized a new common stock repurchase program that will allow the Company to repurchase up to $1.0 million shares of the Company's common stock. This new program commences immediately. Under the new repurchase program, the Company may purchase shares of common stock from time to time through a variety of methods, which may include but are not limited to open market purchases, the implementation of a 10b5-1 plan, privately negotiated transactions and/or any other available methods in accordance with Securities and Exchange Commission and other applicable legal requirements. The repurchase program will remain in effect until the amount authorized has been fully repurchased or until the Company suspends or terminates the program with an outside date of March 31, 2024.

Cargill Financial Limited Consent and Limited Covenant Waiver

On October 31, 2023, the Company, along with certain subsidiaries of the Company, entered into the Limited Consent to Specified Share Repurchase Program and Limited Covenant Waiver with Cargill Financial pursuant to which Cargill Financial (1) granted an exception under Section 6.5 of the Amended Credit Agreements with respect to a share repurchase program in an aggregate amount not to exceed $1,000,000, among other conditions, and (2) waived the financial covenant set forth in Section 6.8(g) of the Amended Credit Agreements for the calendar quarter ended September 30, 2023.

Delisting of Publicly Traded Warrants

On October 17, 2023, the Company received notice from the NYSE that the NYSE had halted trading in the Company's publicly traded warrants. The trading halt of the warrants on the NYSE was due to the low trading price of the warrants.

On October 18, 2023, the NYSE provided written notice to the Company and publicly announced that NYSE Regulation has determined to commence proceedings to delist the warrants and that the warrants are no longer suitable for listing based on "abnormally low" price levels, pursuant to Section 802.01D of the NYSE Listed Company Manual. To effect the delisting, the NYSE will apply to the Securities and Exchange Commission to delist the warrants upon completion of applicable procedures. The Company does not intend to appeal the NYSE's determination.

Trading in the Company's common stock is unaffected and continues to be traded and listed on the NYSE under the ticker symbol "LOCL."

28

Item 6. Exhibits

Exhibit Number	Description
3.1	Certificate of Incorporation of Local Bounti Inc. (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on November 22, 2021).
3.2	Certificate of Amendment to Certificate of Incorporation of Local Bounti Corporation (incorporated by reference to Exhibit 3.2 to the Company’s Annual Report on Form 10-K, filed with the Securities and Exchange Commission on March 30, 2022).
3.3	Certificate of Amendment to Certificate of Incorporation of Local Bounti Corporation (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on June 15, 2023).
3.4	Bylaws of Local Bounti Inc. (incorporated by reference to Exhibit 3.2 to the Company’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on November 22, 2021).
31.1	Certification of Chief Executive Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2	Certification of Chief Financial Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1**	Certification of Chief Executive Officer, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)
32.2**	Certification of Chief Financial Officer, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)
101	The following financial statements from Local Bounti’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2023, formatted in Inline XBRL: (a) Unaudited Condensed Consolidated Statements of Cash Flows, (b) Unaudited Condensed Consolidated Statements of Operations, (c) Unaudited Condensed Consolidated Balance Sheets, and (d) Notes to Unaudited Condensed Consolidated Financial Statements, tagged as blocks of text and including detailed tags.
104	Cover Page Interactive Data File - the cover page from this Quarterly Report on Form 10-Q for the quarter ended September 30, 2023, formatted in Inline XBRL (included in Exhibit 101).

_____________________

** This document is being furnished in accordance with SEC Release Nos. 33‑8212 and 34‑47551.

29

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Local Bounti Corporation

/s/ Anna Fabrega

Name:  Anna Fabrega

Title:    Chief Executive Officer

 Date: November 14, 2023

(Principal Executive Officer)

/s/ Kathleen Valiasek

Name:  Kathleen Valiasek

Title:    Chief Financial Officer

 Date: November 14, 2023

(Principal Financial and Accounting Officer)

30

EX-31.1

Exhibit 31.1

CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Anna Fabrega, certify that:

1.I have reviewed the Quarterly Report on Form 10-Q of Local Bounti Corporation (the “Registrant”);

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;

4.The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:

a.designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and

5.The Registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors (or persons performing the equivalent functions):

a.all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and

b.any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.

		/s/ Anna Fabrega
November 14, 2023	Name:	Anna Fabrega
	Title:	Chief Executive Officer
		(Principal Executive Officer)

EX-31.2

Exhibit 31.2

CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Kathleen Valiasek, certify that:

1.I have reviewed the Quarterly Report on Form 10-Q of Local Bounti Corporation (the “Registrant”);

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;

4.The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:

a.designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and

5.The Registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors (or persons performing the equivalent functions):

a.all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and

b.any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.

		/s/ Kathleen Valiasek
November 14, 2023	Name:	Kathleen Valiasek
	Title:	Chief Financial Officer
		(Principal Financial and Accounting Officer)

EX-32.1

Exhibit 32.1

Certification

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), the undersigned officer of Local Bounti Corporation, a Delaware corporation (the “Company”), hereby certifies that, to her knowledge:

The Quarterly Report on Form 10-Q for the quarter ended September 30, 2023 (the “Report”) of the Company fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

		/s/ Anna Fabrega
November 14, 2023	Name:	Anna Fabrega
	Title:	Chief Executive Officer

The foregoing certification is being furnished solely pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code) and is not being filed as part of the Report or as a separate disclosure document.

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2

Exhibit 32.2

Certification

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), the undersigned officer of Local Bounti Corporation, a Delaware corporation (the “Company”), hereby certifies that, to her knowledge:

The Quarterly Report on Form 10-Q for the quarter ended September 30, 2023 (the “Report”) of the Company fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

		/s/ Kathleen Valiasek
November 14, 2023	Name:	Kathleen Valiasek
	Title:	Chief Financial Officer

The foregoing certification is being furnished solely pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code) and is not being filed as part of the Report or as a separate disclosure document.

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

XML

Cover Page - shares	9 Months Ended
	Sep. 30, 2023	Nov. 06, 2023
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2023
Document Transition Report	false
Entity File Number	001-40125
Entity Registrant Name	Local Bounti Corporation/DE
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	98-1584830
Entity Address, Address Line One	400 W. Main St.
Entity Address, City or Town	Hamilton,
Entity Address, State or Province	MT
Entity Address, Postal Zip Code	59840
City Area Code	(800)
Local Phone Number	640-4016
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		8,271,738
Amendment Flag	false
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q3
Current Fiscal Year End Date	--12-31
Entity Central Index Key	0001840780
Common Stock
Document Information [Line Items]
Title of 12(b) Security	Common Stock, par value of $0.0001 per share
Trading Symbol	LOCL
Security Exchange Name	NYSE
Warrants
Document Information [Line Items]
Title of 12(b) Security	Warrants, thirteen exercisable for one share of Common Stock for $149.50 per share
Trading Symbol	LOCL WS
Security Exchange Name	NYSE

XML

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands		Sep. 30, 2023	Dec. 31, 2022
Current assets
Cash and cash equivalents		$ 11,814	$ 13,666
Restricted cash		6,524	11,272
Accounts receivable, net		2,666	2,691
Inventory, net		4,493	3,594
Prepaid expenses and other current assets		2,295	2,881
Total current assets		27,792	34,104
Property and equipment, net		268,099	157,844
Operating lease right-of-use assets		190	137
Goodwill		38,481	38,481
Intangible assets, net		42,246	47,273
Other assets		674	901
Total assets		377,482	278,740
Current liabilities
Accounts payable		9,041	13,757
Accrued liabilities		15,621	9,426
Operating lease liabilities		91	84
Total current liabilities		24,753	23,267
Long-term debt, net of debt issuance costs		216,958	119,814
Financing obligation		49,057	14,139
Operating lease liabilities, noncurrent		133	187
Warrant liability		8,780	0
Total liabilities		299,681	157,407
Commitments and contingencies (Note 11)
Stockholders' equity
Common stock, $0.0001 par value, 400,000,000 shares authorized, 104,240,153 and 103,700,630 issued and outstanding as of June 30, 2023 and December 31, 2022, respectively	[1]	1	1
Additional paid-in capital		315,574	300,645
Accumulated deficit		(237,774)	(179,313)
Total stockholders' equity		77,801	121,333
Total liabilities and stockholders' equity		$ 377,482	$ 278,740

[1] Prior comparative period share amounts issued and outstanding have been retroactively adjusted to reflect the Reverse Stock Split (as defined below). See Note 2, Summary of Significant Accounting Policies, for additional detail.

XML

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Sep. 30, 2023	Dec. 31, 2022
Statement of Financial Position [Abstract]
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	400,000,000	400,000,000
Common stock, shares issued (in shares)	8,268,639	7,976,980
Common stock, shares outstanding (in shares)	8,268,639	7,976,980

XML

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands		3 Months Ended			9 Months Ended
		Sep. 30, 2023		Sep. 30, 2022	Sep. 30, 2023		Sep. 30, 2022
Income Statement [Abstract]
Sales		$ 6,810		$ 6,285	$ 20,691		$ 12,836
Cost of goods sold	[1],[2],[3]	6,405		5,015	19,155		11,535
Gross profit		405		1,270	1,536		1,301
Operating expenses:
Research and development	[1],[2]	5,001		3,019	12,103		8,933
Selling, general and administrative	[1],[2]	14,406		20,239	47,091		64,741
Total operating expenses		19,407		23,258	59,194		73,674
Loss from operations		(19,002)		(21,988)	(57,658)		(72,373)
Other income (expense):
Change in fair value of warrant liability		1,766		0	16,917		0
Interest expense, net		(7,105)		(5,154)	(17,876)		(12,262)
Other income		83		38	156		96
Net loss		$ (24,258)		$ (27,104)	$ (58,461)		$ (84,539)
Net loss applicable to common stockholders per basic common share:
Basic (in dollars per share)		$ (3.02)	[4]	$ (3.95)	$ (7.41)	[4]	$ (12.73)	[4]
Diluted (in dollars per share)		$ (3.02)		$ (3.95)	$ (7.41)	[4]	$ (12.73)	[4]
Weighted average common shares outstanding:
Basic (in shares)		8,019,561		6,865,001	7,893,665	[4]	6,639,879	[4]
Diluted (in shares)		8,019,561	[4]	6,865,001	7,893,665	[4]	6,639,879	[4]

[1] Amounts include depreciation and amortization as follows:  Three Months Ended September 30,Nine Months Ended
September 30, 2023202220232022 Cost of goods sold $832 $921 $2,662 $1,874  Research and development 722 229 1,754 760  Selling, general and administrative 1,851 1,757 5,763 4,195 Total depreciation and amortization$3,405 $2,907 $10,179 $6,829 

[2] Amounts include stock-based compensation as follows:  Three Months Ended September 30,Nine Months Ended
September 30, 2023202220232022 Cost of goods sold $24 $29 $100 $81  Research and development 343 419 1,676 1,389  Selling, general and administrative 2,898 10,459 11,882 32,146 Total stock-based compensation expense, net of amounts capitalized$3,265 $10,907 $13,658 $33,616 

[3] Amounts include the impact for non-cash increase in cost of goods sold attributable to the fair value basis adjustment to inventory in connection with the Pete's Acquisition (as defined below) as follows:  Three Months Ended September 30,Nine Months Ended
September 30, 2023202220232022 Cost of goods sold $— $— $— $1,042 Total business combination fair value basis adjustment to inventory$— $— $— $1,042 

[4] Prior comparative period share and per share amounts have been retroactively adjusted to reflect the Reverse Stock Split (as defined below). See Note 2, Summary of Significant Accounting Policies, for additional detail.

XML

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Total business combination fair value basis adjustment to inventory	$ 0	$ 0	$ 0	$ 1,042
Total stock-based compensation expense, net of amounts capitalized	3,265	10,907	13,658	33,616
Total depreciation and amortization	3,405	2,907	10,179	6,829
Cost of goods sold
Total business combination fair value basis adjustment to inventory	0	0	0	1,042
Total stock-based compensation expense, net of amounts capitalized	24	29	100	81
Total depreciation and amortization	832	921	2,662	1,874
Research and development
Total stock-based compensation expense, net of amounts capitalized	343	419	1,676	1,389
Total depreciation and amortization	722	229	1,754	760
Selling, general and administrative
Total stock-based compensation expense, net of amounts capitalized	2,898	10,459	11,882	32,146
Total depreciation and amortization	$ 1,851	$ 1,757	$ 5,763	$ 4,195

XML

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands		Total	Voting Common Stock		Additional Paid-in Capital	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021	[1]		6,641,914
Beginning balance at Dec. 31, 2021		$ 101,683	$ 9	[1]	$ 169,916	$ (68,242)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of restricted stock units, net (in shares)	[1]		9,298
Stock-based compensation		11,042			11,042
Net loss		(25,772)				(25,772)
Ending balance (in shares) at Mar. 31, 2022	[1]		6,651,212
Ending balance at Mar. 31, 2022		86,953	$ 9	[1]	180,958	(94,014)
Beginning balance (in shares) at Dec. 31, 2021	[1]		6,641,914
Beginning balance at Dec. 31, 2021		101,683	$ 9	[1]	169,916	(68,242)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss		(84,539)
Ending balance (in shares) at Sep. 30, 2022	[1]		7,256,169
Ending balance at Sep. 30, 2022		119,346	$ 9	[1]	272,118	(152,781)
Beginning balance (in shares) at Mar. 31, 2022	[1]		6,651,212
Beginning balance at Mar. 31, 2022		86,953	$ 9	[1]	180,958	(94,014)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock for business combination (in shares)	[1]		434,969
Issuance of common stock for business combination		50,948			50,948
Issuance of common stock for debt modification (in shares)	[1]		148,687
Issuance of common stock for debt modification		17,416			17,416
Issuance of common stock upon exercise of warrants (in shares)	[1]		1
Vesting of restricted stock units, net (in shares)	[1]		8,859
Stock-based compensation		11,783			11,783
Net loss		(31,663)				(31,663)
Ending balance (in shares) at Jun. 30, 2022	[1]		7,243,728
Ending balance at Jun. 30, 2022		135,437	$ 9	[1]	261,105	(125,677)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of restricted stock units, net (in shares)	[1]		12,441
Stock-based compensation		11,013			11,013
Net loss		(27,104)				(27,104)
Ending balance (in shares) at Sep. 30, 2022	[1]		7,256,169
Ending balance at Sep. 30, 2022		$ 119,346	$ 9	[1]	272,118	(152,781)
Beginning balance (in shares) at Dec. 31, 2022		7,976,980	7,976,980	[1]
Beginning balance at Dec. 31, 2022		$ 121,333	$ 1	[1]	300,645	(179,313)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of restricted stock units, net (in shares)	[1]		41,502
Stock-based compensation		6,361			6,361
Net loss		(23,527)				(23,527)
Ending balance (in shares) at Mar. 31, 2023	[1]		8,018,482
Ending balance at Mar. 31, 2023		$ 104,167	$ 1	[1]	307,006	(202,840)
Beginning balance (in shares) at Dec. 31, 2022		7,976,980	7,976,980	[1]
Beginning balance at Dec. 31, 2022		$ 121,333	$ 1	[1]	300,645	(179,313)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss		$ (58,461)
Ending balance (in shares) at Sep. 30, 2023		8,268,639	8,268,639	[1]
Ending balance at Sep. 30, 2023		$ 77,801	$ 1	[1]	315,574	(237,774)
Beginning balance (in shares) at Mar. 31, 2023	[1]		8,018,482
Beginning balance at Mar. 31, 2023		104,167	$ 1	[1]	307,006	(202,840)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of restricted stock units, net (in shares)	[1]		171,051
Cash paid for fractional shares from the Reverse Stock Split (in shares)	[1]		(552)
Cash paid for fractional shares from the Reverse Stock Split		(3)			(3)
Stock-based compensation		4,792			4,792
Net loss		(10,676)				(10,676)
Ending balance (in shares) at Jun. 30, 2023	[1]		8,188,981
Ending balance at Jun. 30, 2023		98,280	$ 1	[1]	311,795	(213,516)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of restricted stock units, net (in shares)	[1]		79,658
Stock-based compensation		3,779			3,779
Net loss		$ (24,258)				(24,258)
Ending balance (in shares) at Sep. 30, 2023		8,268,639	8,268,639	[1]
Ending balance at Sep. 30, 2023		$ 77,801	$ 1	[1]	$ 315,574	$ (237,774)

[1] Share amounts have been retroactively adjusted to reflect the Reverse Stock Split (as defined below). See Note 2, Summary of Significant Accounting Policies, for additional detail.

XML

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Operating Activities:
Net loss	$ (58,461)	$ (84,539)
Adjustments to reconcile net loss to cash used in operating activities:
Depreciation	5,152	3,477
Amortization	5,027	3,352
Stock-based compensation expense, net of amounts capitalized	13,658	33,616
Bad debt allowance	5	11
Inventory allowance	385	323
Loss on disposal of property and equipment	1,375	252
Gain related to change in fair value of warrant liability	(16,917)	0
Paid-in-kind interest	15,797	0
Amortization of debt issuance costs	5,183	2,791
Interest on financing obligation	144	333
Changes in operating assets and liabilities:
Accounts receivable	20	(68)
Inventory	(1,284)	2
Prepaid expenses and other current assets	1,291	976
Other assets	(649)	2,326
Accounts payable	(493)	5,114
Operating lease liabilities	(104)	6
Accrued liabilities	3,880	(4,849)
Net cash used in operating activities	(25,991)	(36,877)
Investing Activities:
Purchases of property and equipment	(117,241)	(40,863)
Asset acquisition	0	(25,813)
Business combination, net of cash acquired	0	(90,552)
Net cash used in investing activities	(117,241)	(157,228)
Financing Activities:
Proceeds from financing obligation	35,000	0
Proceeds from issuance of debt	101,861	119,351
Payment of debt issuance costs	(226)	(2,342)
Fractional shares paid in cash pursuant to Reverse Stock Split	(3)	0
Net cash provided by financing activities	136,632	117,009
Net decrease in cash and cash equivalents and restricted cash	(6,600)	(77,096)
Cash and cash equivalents and restricted cash and cash equivalents at beginning of period	24,938	101,077
Cash and cash equivalents and restricted cash and cash equivalents at end of period	18,338	23,981
Reconciliation of cash, cash equivalents, and restricted cash from the Unaudited Condensed Consolidated Balance Sheets to the Unaudited Condensed Consolidated Statements of Cash Flows
Cash and cash equivalents	11,814	4,227
Restricted cash and cash equivalents	6,524	19,754
Total cash and cash equivalents and restricted cash and cash equivalents as shown in the Unaudited Condensed Consolidated Statements of Cash Flows	18,338	23,981
Non-cash activities:
Warrants issued in connection with debt modification	25,697	0
Purchases of property and equipment included in accounts payable and accrued liabilities	1,910	7,168
Non-cash equity settlement on employee receivable	176	17,416
Stock-based compensation capitalized to property and equipment, net	1,451	222
Interest capitalized to property and equipment, net	9,486	0
Non-cash financing obligation activity	0	840
Right-of-use asset obtained in exchange for operating lease liability	0	388
Reduction of right of use asset and associated lease liability due to lease cancellation	$ 0	$ (203)

XML

Business Description	9 Months Ended
	Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Business Description	Business DescriptionDescription of the BusinessLocal Bounti Corporation ("Local Bounti" or the "Company") was founded in August 2018 and is headquartered in Hamilton, Montana. The Company is a producer of sustainably grown living lettuce, herbs, and loose leaf lettuce. The Company is a controlled environment agriculture ("CEA") company that utilizes patent pending Stack & Flow TechnologyTM, which is a hybrid of vertical and hydroponic greenhouse farming, to grow healthy food sustainably and affordably. Through the Company's CEA process, its goal is to produce environmentally sustainable products in a manner that will increase harvest efficiency, limit water usage, and reduce the carbon footprint of the production and distribution process.

XML

Summary of Significant Accounting Policies

9 Months Ended

Sep. 30, 2023

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Summary of Significant Accounting Policies

Basis of Presentation and Principles of Consolidation

Management of Local Bounti is responsible for the Unaudited Condensed Consolidated Financial Statements included in this document, which have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP"). The Unaudited Condensed Consolidated Financial Statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in the statements herein.

The Unaudited Condensed Consolidated Financial Statements do not include all of the disclosures required by GAAP for annual financial statements and should be read in conjunction with the audited Consolidated Financial Statements of the Company for the year ended December 31, 2022 (the "Annual Financial Statements") as filed with the SEC on March 31, 2023. In the opinion of the Company, the accompanying Unaudited Condensed Financial Statements contain all adjustments, consisting of only normal recurring adjustments, necessary to fairly present its financial position as of September 30, 2023, its results of operations for the three and nine months ended September 30, 2023 and 2022, its cash flows for the nine months ended September 30, 2023 and 2022, and its stockholders' equity for the three and nine months ended September 30, 2023 and 2022. Results of operations for the interim periods are not necessarily indicative of the results to be expected for the full year ending December 31, 2023 or any future period. The Unaudited Condensed Consolidated Balance Sheet at December 31, 2022 was derived from the Annual Financial Statements but does not contain all of the footnote disclosures from the Annual Financial Statements.

Liquidity

The Company has incurred losses and generated negative cash flows from operations since its inception. At September 30, 2023, the Company had an accumulated deficit of $237.8 million and cash and cash equivalents and restricted cash of $18.3 million.

Cargill Financial expects to provide the Company with $10 million of working capital subject to certain terms and conditions precedent. The Company anticipates closing this transaction in the fourth quarter of this year. The Company has also executed conditional commitment letters from a commercial finance lender for total potential financing of up to approximately $230 million at a floating interest rate of Secured Overnight Financing Rate ("SOFR") plus a margin of 345 basis points per annum (equivalent to approximately 8.8% as of the filing date of this 10-Q Report) in order to fund its 2024 greenfield build and facility expansions. The Company expects to execute definitive documents for such financings in the first quarter of 2024, subject to negotiation of final terms and underwriting commitments.

The Company believes that the additional $10 million of working capital from Cargill Financial, the $230 million from a commercial finance lender, the Company's current cash position, cash generated from product sales, and anticipated cash interest payment deferrals under the Company's credit facilities with Cargill Financial will be adequate to fund the Company’s planned operations over the next 12 months from the issuance of these Unaudited Condensed Consolidated Financial Statements.

The Company also believes additional cash can be secured through other debt or equity financings, if necessary. However, there can be no assurance that equity or debt financing will be available to the Company should it need it or, if available, that the terms will be satisfactory to the Company and not dilutive to existing shareholders. The Company's failure to raise capital as and when needed could have significant negative consequences for its business, financial condition and results of consolidated operations.

Reverse Stock Split Stockholder Approval

On April 3, 2023, the Company's board of directors (the "Board") authorized an amendment to the Company's Certificate of Incorporation to, at the discretion of the Board, effect a reverse stock split of the shares of Local Bounti's common stock, at any time prior to June 30, 2024, at a ratio within a range of 1-for-2 to 1-for-25, with the exact ratio and effective time of the reverse stock split to be determined at the discretion of the Board without further approval or

authorization of the Company's stockholders. The amendment was approved by stockholders at a special meeting of stockholders held on April 26, 2023. On June 4, 2023, the Board approved a 1-for-13 reverse stock split (the "Reverse Stock Split") of the Company's issued and outstanding shares of common stock, par value $0.0001 per share. Trading of the Company's common stock on the NYSE commenced on a split-adjusted basis on June 15, 2023.

As a result of the Reverse Stock Split, every 13 shares of common stock issued and outstanding were automatically reclassified into one new share of common stock without any action on the part of the holders. The Company paid cash in lieu of fractional shares resulting from the Reverse Stock Split. Proportionate adjustments were made to the exercise prices and the number of shares underlying the Company’s outstanding equity awards, as applicable, and warrants exercisable for shares of Common Stock, as well as to the number of shares issuable under the Company’s equity incentive plans and certain existing agreements. Also, for the Company’s outstanding warrants to purchase up to 81,139,179 shares of common stock, every 13 shares issuable under warrants became exercisable for one share of common stock at an exercise price of $149.50 per share of common stock for the Company's publicly traded warrants and $13.00 per share of common stock for the March 2023 Cargill Warrant. See Note 9, Stock-Based Compensation, and Note 10, Net Loss Per Share, for more information. The common stock issued pursuant to the Reverse Stock Split will remain fully paid and non-assessable. The Reverse Stock Split did not affect the number of authorized shares of common stock or the par value of the common stock.

All share and per share amounts presented herein with respect to common stock have been retroactively adjusted to reflect the Reverse Stock Split for all periods presented.

There have been no material changes or updates to the Company's significant accounting policies from those described in the Annual Financial Statements except for the updates noted below.

Derivatives

Equity instruments issued in connection with debt and other equity instruments are required to be evaluated for derivative liability accounting treatment in accordance with Accounting Standards Codification ("ASC") 815, Derivatives and Hedging. Unless certain exception criteria are met, the freestanding financial instrument or embedded feature must be recognized as a separate liability and subsequently measured on the balance sheet at fair value in accordance with ASC 820, Fair Value Measurement.

The Company has evaluated the terms and features of its debt and equity instruments and identified a freestanding equity instrument (the March 2023 Cargill Warrant) issued in connection with the Sixth Amendment that did not meet the criteria necessary to qualify for the derivative scope exception. See Note 6, Debt, and Note 8, Fair Value Measurements, for more information related to the Sixth Amendment and the March 2023 Cargill Warrant, respectively. Due to certain provisions that could result in the issuance of additional shares upon settlement, the warrant instrument did not meet the fixed-for-fixed criteria necessary for the instrument to be classified and recorded within equity. As a result, the warrant is accounted for at fair value until settled through exercise or expiration and is classified as a derivative liability in the Unaudited Condensed Consolidated Balance Sheet at September 30, 2023. The initial $25.7 million fair value of the March 2023 Cargill Warrant was recorded as additional debt discount to the Facilities (as defined below) and a derivative liability in the "Warrant Liability" line item of the Unaudited Condensed Consolidated Balance Sheets. The change in fair value of the warrant will be remeasured each quarter until the instrument is settled or expires with changes in fair value recorded in "Change in fair value of warrant liability" in the Unaudited Condensed Consolidated Statements of Operations. The fair value of the warrant liability is determined using a Black-Scholes-Merton option pricing model. See Note 6, Debt, for more information.

Recently Adopted Accounting Pronouncements

In June 2016, the FASB issued ASU 2016-13, Financial Instruments-Credit Losses (Topic 326), which amends the guidance on reporting credit losses for assets held at amortized cost and available for sale debt securities. For assets held at amortized cost, the amendment eliminates the probable initial recognition threshold in current GAAP and, instead, requires an entity to reflect its current estimate of all expected credit losses. The allowance for credit losses is a valuation account that is deducted from the amortized cost of the financial assets to present the net amount expected to be collected. The Company adopted this guidance on January 1, 2023 using the modified retrospective method. The adoption of this guidance did not have a material impact on the Company's Unaudited Condensed Consolidated Financial Statements.

Recently Issued Accounting Pronouncements

In August 2020, the FASB issued ASU 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity's Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity, which simplifies the accounting for certain financial instruments with characteristics of liability and equity, including convertible instruments and contracts on an entity’s own equity. The standard reduces the number of models used to account for convertible instruments, removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, and requires the if-converted method for calculation of diluted earnings per share for all convertible instruments. The standard is effective for the Company for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2023. Early adoption is permitted. The Company is currently evaluating the impact of this standard on its Consolidated Financial Statements.

XML

Inventory

9 Months Ended

Sep. 30, 2023

Inventory Disclosure [Abstract]

Inventory

Inventory

Inventory consisted of the following:

	September 30,		December 31,
	2023		2022
	(in thousands)
Raw materials	$	2,640	$	2,018
Production(1)	2,660		2,213
Finished goods(1)	269		54
Inventory allowance	(1,076)		(691)
Total inventory, net	$	4,493	$	3,594

_____________________

(1) Approximately $1.8 million of inventory classified as finished goods at December 31, 2022 has been reclassified to the production category at September 30, 2023 to conform the historical presentation to the current period presentation, which reflects the nature and timing of the Company's current harvesting and cost accumulation processes.

XML

Property and Equipment

9 Months Ended

Sep. 30, 2023

Property, Plant and Equipment [Abstract]

Property and Equipment

Property and Equipment

Property and equipment consisted of the following:

	September 30,		December 31,
	2023		2022
	(in thousands)
Machinery, equipment, and vehicles	$	41,528	$	32,774
Land	19,253		19,296
Buildings and leasehold improvements	63,659		55,392
Construction-in-progress	155,073		56,753
Less: Accumulated depreciation	(11,414)		(6,371)
Property and equipment, net	$	268,099	$	157,844

Depreciation expense related to property and equipment was $1.7 million and $1.7 million for the three months ended September 30, 2023 and 2022, respectively, and $5.2 million and $3.5 million for the nine months ended September 30, 2023 and 2022, respectively.

XML

Accrued Liabilities

9 Months Ended

Sep. 30, 2023

Payables and Accruals [Abstract]

Accrued Liabilities

Accrued Liabilities

Accrued liabilities consisted of the following:

	September 30,		December 31,
	2023		2022
	(in thousands)
Interest	$	8,115	$	4,372
Construction	3,104		825
Payroll	1,469		1,470
Production	1,426		1,438
Professional services	322		894
Other	1,185		427
Total accrued liabilities	$	15,621	$	9,426

XML

Debt

9 Months Ended

Sep. 30, 2023

Debt Disclosure [Abstract]

Debt

Debt

Debt consisted of the following:

	September 30,		December 31,
	2023		2022
	(in thousands)
Senior Facility	$	211,927	$	98,442
Subordinated Facility	46,673		42,500
Unamortized deferred financing costs	(41,642)		(21,128)
Total debt	$	216,958	$	119,814

Agreements with Cargill Financial

As previously disclosed in the Company's Annual Financial Statements, Local Bounti Operating Company LLC ("Local Bounti Operating"), the Company and certain subsidiaries entered into with Cargill Financial a First Amendment, a Second Amendment, and a Third Amendment to the Credit Agreement, dated as of September 3, 2021, and the Subordinated Credit Agreement, dated as of September 3, 2021 (the "Original Credit Agreements," and the facilities thereunder, the "Senior Facility" and the "Subordinated Facility," respectively and, collectively, the "Facilities") (which are further described in the Annual Financial Statements) in March 2022, August 2022, and December 2022, respectively. As further described below, Local Bounti Operating, the Company, and certain subsidiaries entered into with Cargill Financial a Fourth Amendment, a Fifth Amendment, and a Sixth Amendment to the Original Credit Agreements (as so amended, collectively referred to as the "Amended Credit Agreements").

Fourth Amendment to the Original Credit Agreements

On January 6, 2023, Local Bounti Operating, the Company and certain subsidiaries entered into a Fourth Amendment to the Original Credit Agreements (the "Fourth Amendment") with Cargill Financial. The Fourth Amendment reduced the minimum liquidity covenant in each of the Original Credit Agreements from $20.0 million to $11.0 million.

Fifth Amendment to the Original Credit Agreements

On March 13, 2023, Local Bounti Operating, the Company and certain subsidiaries entered into a Fifth Amendment to the Original Credit Agreements (the "Fifth Amendment") with Cargill Financial. The Fifth Amendment (i) reduced the amount of cash required to be held in the debt service reserve account by approximately $11.0 million until April 2, 2024, at which time the amount of cash required to be held in the debt service reserve account will be an amount equal to the sum of interest and principal payments that would be required under the Amended Credit Agreements for two calendar quarters; (ii) allowed for the payment in kind of the quarterly interest payment due and payable for the quarter ended March 31, 2023 and allowed for the payment in kind of the unused commitment fee payable for the quarter ended March 31, 2023 which amounted to $4.3 million; and (iii) reduced the minimum liquidity covenant in each of the Amended Credit Agreements from $11.0 million to $1.0 million. The aggregate amount of outstanding loans and undrawn commitments under the Amended Credit Agreements remained at $170.0 million (plus interest and fees paid in kind).

Sixth Amendment to the Original Credit Agreements

On March 28, 2023, Local Bounti Operating, the Company and certain subsidiaries entered into a Sixth Amendment to the Original Credit Agreements (the "Sixth Amendment") with Cargill Financial. The Sixth

Amendment, among other things, (i) expanded the Facilities from $170.0 million to up to $280.0 million (plus, in each case, interest and fees paid in kind), including capital to fund construction at the Company’s facilities in Georgia, Texas, and Washington, subject to certain conditions and at Cargill Financial's discretion; (ii) allowed for the payment in kind of the quarterly interest payment due and payable for the quarter ending June 30, 2023 which amounted to $5.0 million; and (iii) added a minimum production covenant based on a projected production forecast. In consideration for the improved flexibility and the expanded size of the Facilities, Local Bounti issued Cargill Financial 5.4 million warrants with a per share exercise price of $13.00 per share (both number of warrants and per share exercise price adjusted for the Reverse Stock Split) and a 5-year term that expires on March 28, 2028 (the "March 2023 Cargill Warrant").

The Company evaluated the before and after cash flow changes resulting from the Fourth, Fifth and Sixth Amendments and concluded the change in cash flows underlying these cumulative amendments were not significantly different from the cash flows underlying the terms in the Original Credit Agreements; therefore, the Company accounted for these amendments as a modification rather than as an extinguishment. Consequently, the $25.7 million fair value of the March 2023 Cargill Warrant was recorded as an additional debt discount that will amortize to interest expense over the remaining term of the Amended Credit Agreements. Fees paid to non-lender third parties as a result of the modification have been expensed as incurred.

Subsequent to the Sixth Amendment, the interest rate on the Subordinated Facility is 12.5% per annum and the interest rate on the Senior Facility is equal to SOFR plus a margin (which varies between 7.5% to 8.5% depending on the Senior Facility net leverage ratio) per annum, with accrued interest paid quarterly in arrears on the first business day of the subsequent quarter through the maturity date on September 3, 2028. Principal payments under the Senior Facility are payable quarterly, beginning April 1, 2025, based on a 10-year straight line amortization schedule, with the remaining unpaid balance under both the Senior Facility and the Subordinated Facility due on the September 3, 2028 maturity date.

In accordance with the Original Credit Agreements, the Company is required to have a debt service reserve account which is shown as restricted cash and cash equivalents on the Unaudited Condensed Consolidated Balance Sheets. The Fifth Amendment and Sixth Amendment, taken together, reduced the minimum balance to maintain in the debt service reserve account to $0 through March 31, 2025. From and after April 1, 2025, the minimum balance to maintain in the debt service reserve account will be increased to two quarters of scheduled interest payments and two quarters of scheduled principal payments.

The Amended Credit Agreements also contain certain financial covenants that become measurable and effective beginning in the third quarter of 2025, including debt coverage, net leverage, and interest coverage ratios. Additional covenants and other provisions exist that may limit or affect the timing of the Company's ability, among other things, to undergo a merger or consolidation, sell certain assets, create liens, guarantee certain obligations of third parties, make certain investments or acquisitions, and declare dividends or make distributions. The Facilities are secured with a first-priority lien against substantially all of the assets of the Company and its subsidiaries, including their intellectual property. The Company was in compliance with all applicable covenants as of September 30, 2023 other than the financial covenant set forth in Section 6.8(g) of the Amended Credit Agreements. On October 31, 2023, the Company, along with certain subsidiaries of the Company, entered into the Limited Covenant Waiver with Cargill Financial pursuant to which Cargill Financial waived the financial covenant set forth in Section 6.8(g) of the Amended Credit Agreements for the calendar quarter ended September 30, 2023.

XML

Financing Obligation

9 Months Ended

Sep. 30, 2023

Financing Obligation [Abstract]

Financing Obligation

Financing Obligation

On April 27, 2023, Hollandia Real Estate, LLC ("Hollandia"), a wholly-owned subsidiary of the Company, and STORE Master Funding XXXI, LLC ("STORE") consummated a $35 million multi-site sale and leaseback transaction relating to the Carpinteria Facility and the Oxnard Facility (collectively, the "Hollandia Facilities").

In connection with the sale and leaseback transaction, Hollandia and STORE entered into a Master Lease Agreement (the "STORE Lease"), dated April 27, 2023 (the "Effective Date"). Pursuant to the STORE Lease, Hollandia will lease the Hollandia Facilities from STORE, subject to the terms and conditions of the STORE Lease.

The STORE Lease provides for an initial term of 25 years, commencing on the Effective Date and expiring on April 30, 2048 ("Initial Term"). Hollandia has four options to extend the Initial Term for separate renewal terms of five years each (together with the Initial Term, the "Lease Term"). Subject to adjustment as set forth in the STORE Lease, the combined annual minimum rent payable to STORE during the first year of the Lease Term is an amount equal to $3.2 million (the "Base Annual Rent") with payments made monthly, subject to annual rent increases of three percent (3%) of the Base Annual Rent.

The STORE Lease contains certain representations, warranties, covenants, obligations, conditions, indemnification provisions and termination provisions customary for sale and leaseback transactions.

As part of the STORE Lease, Hollandia delivered to STORE a letter of credit in an amount equal to $6.5 million as security for the full and faithful performance by Hollandia of the terms, provisions, covenants and conditions of the STORE Lease. In the event of default under the Lease, STORE shall have the right to draw on the letter of credit to satisfy any monetary obligations under the STORE Lease. The letter of credit shall be released after five (5) years, contingent on achieving certain financial metrics as specified in the STORE Lease. The $6.5 million for the letter of credit is included in "Restricted cash" on the Unaudited Condensed Consolidated Balance Sheets.

The Company accounted for the STORE Lease as a financing transaction in accordance with ASC 842, Leases, as the STORE Lease was determined to be a finance lease. The presence of a finance lease indicates that control of the Hollandia Facilities has not transferred to STORE and, as such, the transaction was deemed a failed sale and leaseback and the proceeds from the sale and leaseback transaction are therefore accounted for as a financing obligation. The leased assets remain on the Unaudited Condensed Consolidated Balance Sheets and will continue to be depreciated over their original estimated useful lives, and the contractual lease payments will be allocated between interest expense (as imputed interest) and repayment of the $35 million financing obligation through April 30, 2048, which is the end of the 25-year lease term and when the Company expects control of the leased assets to transfer to STORE. The Company utilized a rate of 11.06% to calculate imputed interest and recognized $0.7 million and $1.7 million of interest expense for the three and nine months ended September 30, 2023 related to the STORE Lease.

The following table summarizes future financing obligation payments for the Initial Term by fiscal year through April 30, 2048, when control of the leased assets is expected to transfer to STORE:

	STORE Lease Financing Obligation
	(in thousands)
Remainder of 2023	$	809
2024	3,302
2025	3,401
2026	3,503
2027	3,608
Thereafter	102,063
Total financing obligation payments	116,686
Unamortized deferred financing costs	(222)
Amount representing interest	(96,645)
Net financing obligation and asset at end of term	15,239
Total financing obligation	$	35,058

XML

Fair Value Measurements

9 Months Ended

Sep. 30, 2023

Fair Value Disclosures [Abstract]

Fair Value Measurements

Fair Value Measurements

The following table sets forth, by level within the fair value hierarchy, the accounting of the Company’s financial assets and liabilities at fair value on a recurring and nonrecurring basis according to the valuation techniques the Company uses to determine their fair value:

	September 30, 2023
	Level 1		Level 2		Level 3
	(in thousands)
Recurring fair value measurements
Assets:
Money market funds	$	18,231	$	—	$	—
Liabilities:
March 2023 Cargill Warrant Liability	$	—	$	—	$	8,780

	December 31, 2022
	Level 1		Level 2		Level 3
	(in thousands)
Recurring fair value measurements
Assets:
Money market funds	$	13,997	$	—	$	—

The fair value of the Company's money market funds is determined using quoted market prices in active markets for identical assets.

The fair value of the March 2023 Cargill Warrant Liability is determined using a Black-Scholes-Merton option pricing model. The following table presents changes in the Level 3 fair value measurement for the warrant liability on a recurring basis:

	September 30,
	2023
	(in thousands)
Balance as of March 28, 2023 (initial measurement)	$	25,697
Fair value measurement adjustments	(15,151)
Balance as of June 30, 2023	10,546
Fair value measurement adjustments	(1,766)
Balance as of September 30, 2023	$	8,780

The key inputs into the Black-Scholes-Merton option pricing model used to determine the fair value of the 2023 Cargill Warrant Liability were as follows at their measurement dates:

	September 30, 2023		March 28, 2023 (initial measurement)
Input
Share price	$	2.45	$	5.84
Risk-free interest rate	4.60%		3.63%
Volatility	128%		135%
Exercise price	$	13.00	$	13.00
Warrant life (years)	4.5		5.0
Dividend yield	—%		—%

As of September 30, 2023 and December 31, 2022, the carrying value of the Company's cash and cash equivalents, restricted cash, accounts receivable, accounts payable and accrued expenses approximated their respective fair values due to their short-term maturities. There were no transfers of financial instruments between Level 1, Level 2, and Level 3 during the periods presented.

XML

Stock-Based Compensation

9 Months Ended

Sep. 30, 2023

Share-Based Payment Arrangement [Abstract]

Stock-Based Compensation

Stock-Based Compensation

Restricted Common Stock Awards

A summary of the restricted common stock awards ("RSAs") for the nine months ended September 30, 2023 is as follows:

	Number of Shares of Restricted Common Stock Awards1	Average Grant-Date Fair Value1
Unvested at December 31, 2022	288,804	$	24.05
Forfeited	(19,175)	$	36.27
Vested	(46,937)	$	34.19
Unvested at September 30, 2023	222,692	$	20.83

_____________________

(1) Share and per share amounts have been retroactively adjusted to reflect the Reverse Stock Split. See Note 2, Summary of Significant Accounting Policies, for additional detail.

Total expense of RSAs for the three and nine months ended September 30, 2023 was $0.3 million and $0.9 million, respectively. Total expense of RSAs for the three and nine months ended September 30, 2022 was $1.8 million and $3.6 million, respectively. As of September 30, 2023, the total compensation cost related to unvested RSAs not yet recognized is $1.0 million. Unvested RSA expense not yet recognized is expected to be recognized over a weighted average period of 1.12 years.

Restricted Stock Units

A summary of the restricted stock units ("RSUs") activity for the nine months ended September 30, 2023 is as follows:

	Number of RSUs(1)	Average Grant-Date Fair Value(1)
Unvested at December 31, 2022	727,484	$	81.51
Granted	815,620	$	8.62
Forfeited	(59,648)	$	73.98
Vested	(386,141)	$	66.10
Vested, unsettled	42,289	$	73.33
Unvested and outstanding at September 30, 2023	1,139,604	$	34.65

_____________________

(1) Share and per share amounts have been retroactively adjusted to reflect the Reverse Stock Split. See Note 2, Summary of Significant Accounting Policies, for additional detail.

Total expense of RSUs, net of amounts capitalized, for the three and nine months ended September 30, 2023 was $2.9 million and $12.8 million, respectively. Total expense of RSUs for the three and nine months ended September 30, 2022 was $9.1 million and $30.0 million, respectively. As of September 30, 2023, the total compensation cost related to unvested RSUs not yet recognized is $13.9 million. Unvested RSU expense not yet recognized is expected to be recognized over a weighted average period of 2.04 years.

XML

Net Loss Per Share

9 Months Ended

Sep. 30, 2023

Earnings Per Share [Abstract]

Net Loss Per Share

Net Loss Per ShareNet loss per share is computed by dividing net loss by the weighted average number of common stock outstanding during the period. In computing net loss per share, the Company's unvested restricted common stock and warrants are not considered participating securities. Diluted loss per common share is the same as basic loss per common share for the three and nine months ended September 30, 2023 and 2022 because the effects of potentially dilutive items were anti-dilutive given the Company's net loss. Diluted net loss per common share represents an adjustment to basic net loss per share attributable to common stockholders giving effect to all potential common shares that were dilutive and outstanding during the period.

The following table sets forth the computation of the Company's net loss per share attributable to common stockholders:

	Three Months Ended September 30,				Nine Months Ended September 30,
	(in thousands, except share and per share data)(1)
	2023		2022		2023		2022
Net loss	$	(24,258)	$	(27,104)	$	(58,461)	$	(84,539)
Weighted average common stock outstanding, basic and diluted	8,019,561		6,865,001		7,893,665		6,639,879
Net loss per common share, basic and diluted	$	(3.02)	$	(3.95)	$	(7.41)	$	(12.73)

_____________________

(1) Share and per share amounts have been retroactively adjusted to reflect the Reverse Stock Split. See Note 2, Summary of Significant Accounting Policies, for additional detail.

The following table discloses the weighted-average shares outstanding of securities that could potentially dilute basic net earnings per share in the future that were not included in the computation of diluted net loss per share as the impact would be anti-dilutive:

	Three Months Ended September 30,		Nine Months Ended September 30,
	2023	2022	2023	2022
Restricted Stock(1)	222,692	385,465	230,632	401,876
Warrants(2)	6,241,475	887,629	4,554,915	887,625

_____________________

(1) Share amounts have been retroactively adjusted to reflect the Reverse Stock Split. See Note 2, Summary of Significant Accounting Policies, for additional detail.

(2) Subsequent to the Reverse Stock Split, every 13 common shares under warrants becomes exercisable for one share of common stock at an exercise price of $149.50 per share of common stock for the Company's publicly traded warrants and $13.00 per share of common stock for the March 2023 Cargill Warrant, which is reflected in the table above. See Note 2, Summary of Significant Accounting Policies, for additional detail.

XML

Commitments and Contingencies

9 Months Ended

Sep. 30, 2023

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Commitments and Contingencies

Legal Matters

The Company has and may become party to various legal proceedings and other claims that arise in the ordinary course of business. The Company records a liability when it believes that it is probable that a loss will be incurred, and the amount of loss or range of loss can be reasonably estimated. Management is currently not aware of any matters that it expects will have a material adverse effect on the financial position, results of operations, or cash flows of the Company.

XML

Subsequent Events

9 Months Ended

Sep. 30, 2023

Subsequent Events [Abstract]

Subsequent Events

Subsequent Events

Seventh Amendment to Credit Agreements

On October 2, 2023, the Company, along with certain subsidiaries of the Company, entered into a Seventh Amendment to the Original Credit Agreements (the "Seventh Amendment") with Cargill Financial to further amend the Original Credit Agreements. The Seventh Amendment allows for the payment in kind of the quarterly interest payments due and payable for the quarters ending September 30, 2023 and December 31, 2023.

XML

Summary of Significant Accounting Policies (Policies)

9 Months Ended

Sep. 30, 2023

Accounting Policies [Abstract]

Basis of Presentation

Basis of Presentation and Principles of Consolidation

Management of Local Bounti is responsible for the Unaudited Condensed Consolidated Financial Statements included in this document, which have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP"). The Unaudited Condensed Consolidated Financial Statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in the statements herein.

The Unaudited Condensed Consolidated Financial Statements do not include all of the disclosures required by GAAP for annual financial statements and should be read in conjunction with the audited Consolidated Financial Statements of the Company for the year ended December 31, 2022 (the "Annual Financial Statements") as filed with the SEC on March 31, 2023. In the opinion of the Company, the accompanying Unaudited Condensed Financial Statements contain all adjustments, consisting of only normal recurring adjustments, necessary to fairly present its financial position as of September 30, 2023, its results of operations for the three and nine months ended September 30, 2023 and 2022, its cash flows for the nine months ended September 30, 2023 and 2022, and its stockholders' equity for the three and nine months ended September 30, 2023 and 2022. Results of operations for the interim periods are not necessarily indicative of the results to be expected for the full year ending December 31, 2023 or any future period. The Unaudited Condensed Consolidated Balance Sheet at December 31, 2022 was derived from the Annual Financial Statements but does not contain all of the footnote disclosures from the Annual Financial Statements.

Principles of Consolidation

Basis of Presentation and Principles of Consolidation

Management of Local Bounti is responsible for the Unaudited Condensed Consolidated Financial Statements included in this document, which have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP"). The Unaudited Condensed Consolidated Financial Statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in the statements herein.

The Unaudited Condensed Consolidated Financial Statements do not include all of the disclosures required by GAAP for annual financial statements and should be read in conjunction with the audited Consolidated Financial Statements of the Company for the year ended December 31, 2022 (the "Annual Financial Statements") as filed with the SEC on March 31, 2023. In the opinion of the Company, the accompanying Unaudited Condensed Financial Statements contain all adjustments, consisting of only normal recurring adjustments, necessary to fairly present its financial position as of September 30, 2023, its results of operations for the three and nine months ended September 30, 2023 and 2022, its cash flows for the nine months ended September 30, 2023 and 2022, and its stockholders' equity for the three and nine months ended September 30, 2023 and 2022. Results of operations for the interim periods are not necessarily indicative of the results to be expected for the full year ending December 31, 2023 or any future period. The Unaudited Condensed Consolidated Balance Sheet at December 31, 2022 was derived from the Annual Financial Statements but does not contain all of the footnote disclosures from the Annual Financial Statements.

Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements

Recently Adopted Accounting Pronouncements

In June 2016, the FASB issued ASU 2016-13, Financial Instruments-Credit Losses (Topic 326), which amends the guidance on reporting credit losses for assets held at amortized cost and available for sale debt securities. For assets held at amortized cost, the amendment eliminates the probable initial recognition threshold in current GAAP and, instead, requires an entity to reflect its current estimate of all expected credit losses. The allowance for credit losses is a valuation account that is deducted from the amortized cost of the financial assets to present the net amount expected to be collected. The Company adopted this guidance on January 1, 2023 using the modified retrospective method. The adoption of this guidance did not have a material impact on the Company's Unaudited Condensed Consolidated Financial Statements.

Recently Issued Accounting Pronouncements

In August 2020, the FASB issued ASU 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity's Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity, which simplifies the accounting for certain financial instruments with characteristics of liability and equity, including convertible instruments and contracts on an entity’s own equity. The standard reduces the number of models used to account for convertible instruments, removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, and requires the if-converted method for calculation of diluted earnings per share for all convertible instruments. The standard is effective for the Company for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2023. Early adoption is permitted. The Company is currently evaluating the impact of this standard on its Consolidated Financial Statements.

XML

Inventory (Tables)

9 Months Ended

Sep. 30, 2023

Inventory Disclosure [Abstract]

Schedule of Components of Inventories

Inventory consisted of the following:

	September 30,		December 31,
	2023		2022
	(in thousands)
Raw materials	$	2,640	$	2,018
Production(1)	2,660		2,213
Finished goods(1)	269		54
Inventory allowance	(1,076)		(691)
Total inventory, net	$	4,493	$	3,594

_____________________

(1) Approximately $1.8 million of inventory classified as finished goods at December 31, 2022 has been reclassified to the production category at September 30, 2023 to conform the historical presentation to the current period presentation, which reflects the nature and timing of the Company's current harvesting and cost accumulation processes.

XML

Property and Equipment (Tables)

9 Months Ended

Sep. 30, 2023

Property, Plant and Equipment [Abstract]

Schedule of Property and Equipment

Property and equipment consisted of the following:

	September 30,		December 31,
	2023		2022
	(in thousands)
Machinery, equipment, and vehicles	$	41,528	$	32,774
Land	19,253		19,296
Buildings and leasehold improvements	63,659		55,392
Construction-in-progress	155,073		56,753
Less: Accumulated depreciation	(11,414)		(6,371)
Property and equipment, net	$	268,099	$	157,844

XML

Accrued Liabilities (Tables)

9 Months Ended

Sep. 30, 2023

Payables and Accruals [Abstract]

Schedule of Accrued Liabilities

Accrued liabilities consisted of the following:

	September 30,		December 31,
	2023		2022
	(in thousands)
Interest	$	8,115	$	4,372
Construction	3,104		825
Payroll	1,469		1,470
Production	1,426		1,438
Professional services	322		894
Other	1,185		427
Total accrued liabilities	$	15,621	$	9,426

XML

Debt (Tables)

9 Months Ended

Sep. 30, 2023

Debt Disclosure [Abstract]

Schedule of Debt

Debt consisted of the following:

	September 30,		December 31,
	2023		2022
	(in thousands)
Senior Facility	$	211,927	$	98,442
Subordinated Facility	46,673		42,500
Unamortized deferred financing costs	(41,642)		(21,128)
Total debt	$	216,958	$	119,814

XML

Financing Obligation (Tables)

9 Months Ended

Sep. 30, 2023

Financing Obligation [Abstract]

Schedule of Future Payments for Financing Obligations

The following table summarizes future financing obligation payments for the Initial Term by fiscal year through April 30, 2048, when control of the leased assets is expected to transfer to STORE:

	STORE Lease Financing Obligation
	(in thousands)
Remainder of 2023	$	809
2024	3,302
2025	3,401
2026	3,503
2027	3,608
Thereafter	102,063
Total financing obligation payments	116,686
Unamortized deferred financing costs	(222)
Amount representing interest	(96,645)
Net financing obligation and asset at end of term	15,239
Total financing obligation	$	35,058

XML

Fair Value Measurements (Tables)

9 Months Ended

Sep. 30, 2023

Fair Value Disclosures [Abstract]

Schedule of Fair Value Assets And Liabilities Measured on Recurring Basis

The following table sets forth, by level within the fair value hierarchy, the accounting of the Company’s financial assets and liabilities at fair value on a recurring and nonrecurring basis according to the valuation techniques the Company uses to determine their fair value:

	September 30, 2023
	Level 1		Level 2		Level 3
	(in thousands)
Recurring fair value measurements
Assets:
Money market funds	$	18,231	$	—	$	—
Liabilities:
March 2023 Cargill Warrant Liability	$	—	$	—	$	8,780

	December 31, 2022
	Level 1		Level 2		Level 3
	(in thousands)
Recurring fair value measurements
Assets:
Money market funds	$	13,997	$	—	$	—

Schedule of Changes in Level 3 Fair Value Measurement for the Warrant Liability

The following table presents changes in the Level 3 fair value measurement for the warrant liability on a recurring basis:

	September 30,
	2023
	(in thousands)
Balance as of March 28, 2023 (initial measurement)	$	25,697
Fair value measurement adjustments	(15,151)
Balance as of June 30, 2023	10,546
Fair value measurement adjustments	(1,766)
Balance as of September 30, 2023	$	8,780

Fair Value Measurement Inputs and Valuation Techniques

The key inputs into the Black-Scholes-Merton option pricing model used to determine the fair value of the 2023 Cargill Warrant Liability were as follows at their measurement dates:

	September 30, 2023		March 28, 2023 (initial measurement)
Input
Share price	$	2.45	$	5.84
Risk-free interest rate	4.60%		3.63%
Volatility	128%		135%
Exercise price	$	13.00	$	13.00
Warrant life (years)	4.5		5.0
Dividend yield	—%		—%

XML

Stock-Based Compensation (Tables)

9 Months Ended

Sep. 30, 2023

Share-Based Payment Arrangement [Abstract]

Summary of Restricted Common Stock Awards, Activity

A summary of the restricted common stock awards ("RSAs") for the nine months ended September 30, 2023 is as follows:

	Number of Shares of Restricted Common Stock Awards1	Average Grant-Date Fair Value1
Unvested at December 31, 2022	288,804	$	24.05
Forfeited	(19,175)	$	36.27
Vested	(46,937)	$	34.19
Unvested at September 30, 2023	222,692	$	20.83

_____________________

(1) Share and per share amounts have been retroactively adjusted to reflect the Reverse Stock Split. See Note 2, Summary of Significant Accounting Policies, for additional detail.

Summary of Restricted Stock Unit, Activity

A summary of the restricted stock units ("RSUs") activity for the nine months ended September 30, 2023 is as follows:

	Number of RSUs(1)	Average Grant-Date Fair Value(1)
Unvested at December 31, 2022	727,484	$	81.51
Granted	815,620	$	8.62
Forfeited	(59,648)	$	73.98
Vested	(386,141)	$	66.10
Vested, unsettled	42,289	$	73.33
Unvested and outstanding at September 30, 2023	1,139,604	$	34.65

_____________________

(1) Share and per share amounts have been retroactively adjusted to reflect the Reverse Stock Split. See Note 2, Summary of Significant Accounting Policies, for additional detail.

XML

Net Loss Per Share (Tables)

9 Months Ended

Sep. 30, 2023

Earnings Per Share [Abstract]

Schedule of Net Loss Per Share, Basic and Diluted

The following table sets forth the computation of the Company's net loss per share attributable to common stockholders:

	Three Months Ended September 30,				Nine Months Ended September 30,
	(in thousands, except share and per share data)(1)
	2023		2022		2023		2022
Net loss	$	(24,258)	$	(27,104)	$	(58,461)	$	(84,539)
Weighted average common stock outstanding, basic and diluted	8,019,561		6,865,001		7,893,665		6,639,879
Net loss per common share, basic and diluted	$	(3.02)	$	(3.95)	$	(7.41)	$	(12.73)

_____________________

(1) Share and per share amounts have been retroactively adjusted to reflect the Reverse Stock Split. See Note 2, Summary of Significant Accounting Policies, for additional detail.

Schedule of Antidilutive Securities Weighted-average Shares Outstanding of Securities That Could Potentially Dilute Basic Net Loss Per Share

The following table discloses the weighted-average shares outstanding of securities that could potentially dilute basic net earnings per share in the future that were not included in the computation of diluted net loss per share as the impact would be anti-dilutive:

	Three Months Ended September 30,		Nine Months Ended September 30,
	2023	2022	2023	2022
Restricted Stock(1)	222,692	385,465	230,632	401,876
Warrants(2)	6,241,475	887,629	4,554,915	887,625

_____________________

(1) Share amounts have been retroactively adjusted to reflect the Reverse Stock Split. See Note 2, Summary of Significant Accounting Policies, for additional detail.

(2) Subsequent to the Reverse Stock Split, every 13 common shares under warrants becomes exercisable for one share of common stock at an exercise price of $149.50 per share of common stock for the Company's publicly traded warrants and $13.00 per share of common stock for the March 2023 Cargill Warrant, which is reflected in the table above. See Note 2, Summary of Significant Accounting Policies, for additional detail.

XML

Summary of Significant Accounting Policies (Details)	Nov. 14, 2023 USD ($)	Jun. 04, 2023 $ / shares shares	Apr. 03, 2023	Sep. 30, 2023 USD ($) $ / shares	Mar. 28, 2023 USD ($) $ / shares	Dec. 31, 2022 USD ($) $ / shares	Sep. 30, 2022 USD ($)	Dec. 31, 2021 USD ($)
Class of Stock [Line Items]
Accumulated deficit				$ (237,774,000)		$ (179,313,000)
Cash and cash equivalents and restricted cash				$ 18,338,000		$ 24,938,000	$ 23,981,000	$ 101,077,000
Stock splits ratio		0.0769
Common stock, par value (in dollars per share) | $ / shares		$ 0.0001		$ 0.0001		$ 0.0001
Number of securities called by each warrant (in shares) | shares		0.0769
Number of common stock called by warrants (in shares) | shares		81,139,179
Warrant exercise price (in dollars per share) | $ / shares		$ 149.50
Warrant liability				$ 8,780,000		$ 0
March 2023 Cargill Warrant
Class of Stock [Line Items]
Warrant liability				$ 25,700,000
Sixth Amendment To Original Credit Agreement | Loans Payable
Class of Stock [Line Items]
Debt, face amount					$ 280,000,000
Sixth Amendment To Original Credit Agreement | March 2023 Cargill Warrant | Loans Payable
Class of Stock [Line Items]
Warrant exercise price (in dollars per share) | $ / shares					$ 13.00
Subsequent Event
Class of Stock [Line Items]
Debt, conditional working capital borrowing capacity, amount	$ 10,000,000
Subsequent Event | Conditional Commitment Letters
Class of Stock [Line Items]
Debt, face amount	$ 230,000,000
Debt effective interest rate	8.80%
Subsequent Event | Conditional Commitment Letters | Secured Overnight Financing Rate (SOFR)
Class of Stock [Line Items]
Debt basis spread on variable rate	3.45%
Minimum
Class of Stock [Line Items]
Stock splits ratio			0.50
Maximum
Class of Stock [Line Items]
Stock splits ratio			0.04

XML

Inventory (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Inventory [Line Items]
Raw materials	$ 2,640	$ 2,018
Production	2,660	2,213
Finished goods	269	54
Inventory allowance	(1,076)	(691)
Total inventory, net	4,493	$ 3,594
Revision of prior period, reclassification, adjustment
Inventory [Line Items]
Production	1,800
Finished goods	$ (1,800)

XML

Property and Equipment (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Property, Plant and Equipment [Line Items]
Less: Accumulated depreciation	$ (11,414)		$ (11,414)		$ (6,371)
Property and equipment, net	268,099		268,099		157,844
Depreciation	1,700	$ 1,700	5,152	$ 3,477
Machinery, equipment, and vehicles
Property, Plant and Equipment [Line Items]
Property and equipment, gross	41,528		41,528		32,774
Land
Property, Plant and Equipment [Line Items]
Property and equipment, gross	19,253		19,253		19,296
Buildings and leasehold improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	63,659		63,659		55,392
Construction-in-progress
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 155,073		$ 155,073		$ 56,753

XML

Accrued Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Payables and Accruals [Abstract]
Interest	$ 8,115	$ 4,372
Construction	3,104	825
Payroll	1,469	1,470
Production	1,426	1,438
Professional services	322	894
Other	1,185	427
Total accrued liabilities	$ 15,621	$ 9,426

XML

Debt - Schedule of Debt (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Debt Instrument [Line Items]
Unamortized deferred financing costs	$ (41,642)	$ (21,128)
Total debt	216,958	119,814
Senior Facility
Debt Instrument [Line Items]
Long-term debt, gross	211,927	98,442
Subordinated Facility
Debt Instrument [Line Items]
Long-term debt, gross	$ 46,673	$ 42,500

XML

Debt - Narrative (Details) $ / shares in Units, shares in Millions		6 Months Ended	9 Months Ended
	Mar. 13, 2023 USD ($) quarter	Sep. 30, 2023 USD ($)	Sep. 30, 2023 USD ($)	Jun. 04, 2023 $ / shares	Mar. 28, 2023 USD ($) quarter $ / shares shares	Jan. 06, 2023 USD ($)	Jan. 05, 2023 USD ($)	Dec. 31, 2022 USD ($)
Debt Instrument [Line Items]
Warrant exercise price (in dollars per share) | $ / shares				$ 149.50
Warrant liability		$ 8,780,000	$ 8,780,000					$ 0
March 2023 Cargill Warrant
Debt Instrument [Line Items]
Warrant liability		$ 25,700,000	$ 25,700,000
Loans Payable | First Amendment of the Credit Agreements
Debt Instrument [Line Items]
Debt covenant, minimum liquidity amount							$ 20,000,000
Loans Payable | Fourth Amendment of the Credit Agreements
Debt Instrument [Line Items]
Debt covenant, minimum liquidity amount						$ 11,000,000
Loans Payable | Fifth Amendment of the Credit Agreements
Debt Instrument [Line Items]
Debt covenant, minimum liquidity amount	$ 1,000,000
Debt covenant, debt service reserve account requirement	$ 11,000,000
Debt covenant, debt service reserve account requirement, number of calendar quarters | quarter	2
Debt covenant, payment in kind of quarterly interest and unused commitment fee payable	$ 4,300,000
Debt, face amount	$ 170,000,000
Loans Payable | Sixth Amendment To Original Credit Agreement
Debt Instrument [Line Items]
Debt covenant, debt service reserve account requirement					$ 0
Debt, face amount					280,000,000
Debt covenant, payment in kind of quarterly interest payment due and payable					$ 5,000,000
Debt covenant, debt service reserve account requirement, number of quarters of scheduled interest payments | quarter					2
Debt covenant, debt service reserve account requirement, number of quarters of scheduled amortization payments | quarter					2
Loans Payable | Sixth Amendment To Original Credit Agreement | March 2023 Cargill Warrant
Debt Instrument [Line Items]
Warrants outstanding (in shares) | shares					5.4
Warrant exercise price (in dollars per share) | $ / shares					$ 13.00
Warrants term					5 years
Loans Payable | Subordinated Facility
Debt Instrument [Line Items]
Debt effective interest rate		12.50%	12.50%
Loans Payable | Senior Facility
Debt Instrument [Line Items]
Debt instrument, amortization period			10 years
Loans Payable | Senior Facility | Minimum | Secured Overnight Financing Rate (SOFR)
Debt Instrument [Line Items]
Debt basis spread on variable rate		7.50%
Loans Payable | Senior Facility | Maximum | Secured Overnight Financing Rate (SOFR)
Debt Instrument [Line Items]
Debt basis spread on variable rate		8.50%

XML

Financing Obligation - Narrative (Details) $ in Thousands		3 Months Ended	9 Months Ended
	Apr. 27, 2023 USD ($) extensionOption	Sep. 30, 2023 USD ($)	Sep. 30, 2023 USD ($)	Sep. 30, 2022 USD ($)
Sale Leaseback Transaction [Line Items]
Interest on financing obligation			$ 144	$ 333
STORE Lease
Sale Leaseback Transaction [Line Items]
Sale and leaseback transaction, amount	$ 35,000
Sale and leaseback transaction, initial term	25 years
Sale and leaseback transaction, options to extend | extensionOption	4
Sale and leaseback transaction, renewal terms	5 years
Sale and leaseback transaction, base annual rent	$ 3,200
Sale and leaseback transaction, base annual rent, increase percentage	3.00%
Letters of credit included in restricted cash and cash equivalents	$ 6,500
Sale and leaseback transaction, letter of credit term	5 years
Sale and finance leaseback transaction, imputed interest rate		11.06%	11.06%
Interest on financing obligation		$ 700	$ 1,700

XML

Financing Obligation - Schedule of Future Financing Obligation Payments (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Sale Leaseback Transaction [Line Items]
Total financing obligation	$ 49,057	$ 14,139
STORE Lease
Sale Leaseback Transaction [Line Items]
Remainder of 2023	809
2024	3,302
2025	3,401
2026	3,503
2027	3,608
Thereafter	102,063
Total financing obligation payments	116,686
Unamortized deferred financing costs	(222)
Amount representing interest	(96,645)
Net financing obligation and asset at end of term	15,239
Total financing obligation	$ 35,058

XML

Fair Value Measurements - Schedule of Fair Value Assets And Liabilities Measured on Recurring Basis (Details) - Fair Value, Recurring - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Level 1 | Warrants
Liabilities:
March 2023 Cargill Warrant Liability	$ 0
Level 1 | Money market funds
Assets:
Assets, fair value	18,231	$ 13,997
Level 2 | Warrants
Liabilities:
March 2023 Cargill Warrant Liability	0
Level 2 | Money market funds
Assets:
Assets, fair value	0	0
Level 3 | Warrants
Liabilities:
March 2023 Cargill Warrant Liability	8,780
Level 3 | Money market funds
Assets:
Assets, fair value	$ 0	$ 0

XML

Fair Value Measurements - Schedule of Changes in Level 3 Fair Value Measurement for the Warrant Liability (Details) - Fair Value, Recurring - Warrants - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2023	Jun. 30, 2023
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	$ 10,546	$ 25,697
Fair value measurement adjustments	(1,766)	(15,151)
Ending balance	$ 8,780	$ 10,546

XML

Fair Value Measurements - Fair Value Measurement Key Inputs (Details)	Sep. 30, 2023 $ / shares year	Mar. 28, 2023 $ / shares year
Share price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants, measurement input	2.45	5.84
Risk-free interest rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants, measurement input	0.0460	0.0363
Volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants, measurement input	1.28	1.35
Exercise price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants, measurement input	13.00	13.00
Warrant life (years)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants, measurement input | year	4.5	5.0
Dividend yield
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants, measurement input	0	0

XML

Stock-Based Compensation - Restricted Common Stock Awards and Restricted Stock Units Activity (Details)	9 Months Ended
	Sep. 30, 2023 $ / shares shares
Restricted Common Stock Awards
Number of Shares of Restricted Common Stock Awards
Unvested beginning balance (in shares) | shares	288,804
Forfeited (in shares) | shares	(19,175)
Vested (in shares) | shares	(46,937)
Unvested ending balance (in shares) | shares	222,692
Average Grant-Date Fair Value
Unvested beginning balance (in dollars per share) | $ / shares	$ 24.05
Forfeited (in dollars per share) | $ / shares	36.27
Vested (in dollars per share) | $ / shares	34.19
Unvested ending balance (in dollars per share) | $ / shares	$ 20.83
Restricted Stock Units (RSUs)
Number of Shares of Restricted Common Stock Awards
Unvested beginning balance (in shares) | shares	727,484
Granted (in shares) | shares	815,620
Forfeited (in shares) | shares	(59,648)
Vested (in shares) | shares	(386,141)
Vested, unsettled (in shares) | shares	42,289
Unvested ending balance (in shares) | shares	1,139,604
Average Grant-Date Fair Value
Unvested beginning balance (in dollars per share) | $ / shares	$ 81.51
Granted (in dollars per share) | $ / shares	8.62
Forfeited (in dollars per share) | $ / shares	73.98
Vested (in dollars per share) | $ / shares	66.10
Vested, unsettled (in dollars per share) | $ / shares	73.33
Unvested ending balance (in dollars per share) | $ / shares	$ 34.65

XML

Stock-Based Compensation - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 3,265	$ 10,907	$ 13,658	$ 33,616
Restricted Common Stock Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	300	1,800	900	3,600
Cost not yet recognized, amount	1,000		$ 1,000
Cost not yet recognized, period for recognition			1 year 1 month 13 days
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	2,900	$ 9,100	$ 12,800	$ 30,000
Cost not yet recognized, amount	$ 13,900		$ 13,900
Cost not yet recognized, period for recognition			2 years 14 days

XML

Net Loss Per Share - Schedule of Net Loss Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended							9 Months Ended
	Sep. 30, 2023		Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2023		Sep. 30, 2022
Earnings Per Share [Abstract]
Net loss	$ (24,258)		$ (10,676)	$ (23,527)	$ (27,104)	$ (31,663)	$ (25,772)	$ (58,461)		$ (84,539)
Weighted average common stock outstanding, basic (in shares)	8,019,561				6,865,001			7,893,665	[1]	6,639,879	[1]
Weighted average common stock outstanding, diluted (in shares)	8,019,561	[1]			6,865,001			7,893,665	[1]	6,639,879	[1]
Net loss per common share, basic (in dollars per share)	$ (3.02)	[1]			$ (3.95)			$ (7.41)	[1]	$ (12.73)	[1]
Net loss per common share, diluted (in dollars per share)	$ (3.02)				$ (3.95)			$ (7.41)	[1]	$ (12.73)	[1]

[1] Prior comparative period share and per share amounts have been retroactively adjusted to reflect the Reverse Stock Split (as defined below). See Note 2, Summary of Significant Accounting Policies, for additional detail.

XML

Net Loss Per Share - Antidilutive Securities Excluded from Computation of Net Loss Per Share (Details)		3 Months Ended		9 Months Ended
	Jun. 04, 2023 $ / shares shares	Sep. 30, 2023 shares	Sep. 30, 2022 shares	Sep. 30, 2023 shares	Sep. 30, 2022 shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Stock splits ratio	0.0769
Number of securities called by each warrant (in shares)	0.0769
Warrant exercise price (in dollars per share) | $ / shares	$ 149.50
Restricted Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)		222,692	385,465	230,632	401,876
Warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)		6,241,475	887,629	4,554,915	887,625